• ThetaHealing® Basic DNA Practitioner in Delhi by Romshri - ThetaHealing® Basic DNA Practitioner in Delhi by Romshri Duration: 3 Days. 1st to 3rd October, 2019 Place: South Delhi, India Become a ThetaHealing® Basic DNA Practitioner! What is ThetaHealing? The ThetaHealing technique is a meditation technique utilizing a spiritual philosophy with the purpose of improvement in mind, body and spirit while getting closer to the Creator of All That Is (our God has many names and we call him Creator). It is a focused prayer to the Creator and allows you to train your mind, body and spirit to clear limiting beliefs and live life with positive thoughts, developing virtues in all that we do. Through meditation and prayer, the ThetaHealing Technique creates a positive lifestyle. The ThetaHealing technique is always taught to be used in conjunction with conventional medicine. It teaches how to put to use one's own natural intuition, relying upon unconditional love of Creator Of All That Is to do the actual “work.” We believe by focused prayer utilizing a “Theta” and "delta" brainwave (incorporating physics and quantum physics), you can actually witness the Creator Of All That Is create instantaneous physical and emotional wellbeing. We have learned that through the ThetaHealing Technique intuitive abilities can be used to bring about spontaneous changes and physical and emotional wellbeing. What this seminar teaches? Basic DNA introduces ThetaHealing techniques and focuses on activating the 12 strands of DNA within each participant. ThetaHealing-Basic-DNA Students experience an opening to the Unconditional Love of the Creator. The heart of this seminar is the practice of techniques that allow you to change life patterns held in place by core, genetic, historic and soul beliefs, either self inflicted or externally imposed. In the ThetaHealing technique we believe you inherit beliefs and emotions from your ancestors. This level we call the genetic level The student will learn to identify his/her own beliefs as well as to practice pulling them for others in the seminar. This practice can quickly reveal systems of belief, showing the body how to replace limiting beliefs or feelings with positive ones. Recent articles have proven genetic beliefs can be passed down. Other topics and exercises include: Learn why we create things in our life and what we learn from it Learn discernment when working with guides and guardian angels Introduction to manifestation in your life Future readings Balancing your moods Soul mates, wayward and implants Seven Planes of Existence The Power of Connecting to the Creator of All the Is, By the end of the ThetaHealing seminars, the student is prepared to become a practitioner of the ThetaHealing Technique as a ThetaHealer®. CERTIFICATION BY: www.thetahealing.com Seminar Includes: ThetaHealing Book and ThetaHealing Basic Practitioners Manual This seminar is taught in 3 consecutive days. To register: info@awakeninglove.co Class include: 3 days lunch and tea, ThetaHealing manual and book, 5 Year Official Contract to Practice as a ThetaHealer® . This Class is Packed with Lots of Knowledge and Practical Exercises, Divine Energies and of course Lots of FUN.!!!!!!!!! Facilitator: Romshri ( http://awakeninglove.co/romshri-ashesh/) NOTE: NO Pre-requisite and NO Religious affiliation, Any enthusiastic individual can do this Course. Prerequisites: None. Investment: 32,000 INR Early bird Scholarship of 20% off!! Individual, Family & group scholarships available. For details & registration feel free to write to: info@awakeninglove.co (Added: Sun Sep 22 2019 Hits: 8 Rating: 0.00 Votes: 0) Rate It

• ThetaHealing® Basic DNA Practitioner in Delhi by Romshri - ThetaHealing® Basic DNA Practitioner in Delhi by Romshri Duration: 3 Days. 1st to 3rd October, 2019 Place: South Delhi, India Become a ThetaHealing® Basic DNA Practitioner! What is ThetaHealing? The ThetaHealing technique is a meditation technique utilizing a spiritual philosophy with the purpose of improvement in mind, body and spirit while getting closer to the Creator of All That Is (our God has many names and we call him Creator). It is a focused prayer to the Creator and allows you to train your mind, body and spirit to clear limiting beliefs and live life with positive thoughts, developing virtues in all that we do. Through meditation and prayer, the ThetaHealing Technique creates a positive lifestyle. The ThetaHealing technique is always taught to be used in conjunction with conventional medicine. It teaches how to put to use one's own natural intuition, relying upon unconditional love of Creator Of All That Is to do the actual “work.” We believe by focused prayer utilizing a “Theta” and "delta" brainwave (incorporating physics and quantum physics), you can actually witness the Creator Of All That Is create instantaneous physical and emotional wellbeing. We have learned that through the ThetaHealing Technique intuitive abilities can be used to bring about spontaneous changes and physical and emotional wellbeing. What this seminar teaches? Basic DNA introduces ThetaHealing techniques and focuses on activating the 12 strands of DNA within each participant. ThetaHealing-Basic-DNA Students experience an opening to the Unconditional Love of the Creator. The heart of this seminar is the practice of techniques that allow you to change life patterns held in place by core, genetic, historic and soul beliefs, either self inflicted or externally imposed. In the ThetaHealing technique we believe you inherit beliefs and emotions from your ancestors. This level we call the genetic level The student will learn to identify his/her own beliefs as well as to practice pulling them for others in the seminar. This practice can quickly reveal systems of belief, showing the body how to replace limiting beliefs or feelings with positive ones. Recent articles have proven genetic beliefs can be passed down. Other topics and exercises include: Learn why we create things in our life and what we learn from it Learn discernment when working with guides and guardian angels Introduction to manifestation in your life Future readings Balancing your moods Soul mates, wayward and implants Seven Planes of Existence The Power of Connecting to the Creator of All the Is, By the end of the ThetaHealing seminars, the student is prepared to become a practitioner of the ThetaHealing Technique as a ThetaHealer®. CERTIFICATION BY: www.thetahealing.com Seminar Includes: ThetaHealing Book and ThetaHealing Basic Practitioners Manual This seminar is taught in 3 consecutive days. To register: info@awakeninglove.co Class include: 3 days lunch and tea, ThetaHealing manual and book, 5 Year Official Contract to Practice as a ThetaHealer® . This Class is Packed with Lots of Knowledge and Practical Exercises, Divine Energies and of course Lots of FUN.!!!!!!!!! Facilitator: Romshri ( http://awakeninglove.co/romshri-ashesh/) NOTE: NO Pre-requisite and NO Religious affiliation, Any enthusiastic individual can do this Course. Prerequisites: None. Investment: 32,000 INR Early bird Scholarship of 20% off!! Individual, Family & group scholarships available. For details & registration feel free to write to: info@awakeninglove.co (Added: Sun Sep 22 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• ROOT Periodontal & Implant Center Expands to Frisco - Frisco, TX - September 21, 2019 - Frisco residents are being offered the best in dental services with the opening of a new clinic by ROOT Periodontal & Implant Center. ROOT Periodontal and Implant Center is dedicated to identifying and addressing the periodontal disease and providing personalized care programs for patients with services, including regular maintenance and dental implants. From their hub in Carrollton, they have built an exceptional reputation for attention to detail and commitment to contributing to the client's overall health in a friendly environment. So they are now delighted to be able to offer these services to residents and families of Frisco from their new clinic at 6340 Preston Rd #100. The team are available for appointments and further information about their services on 469-489-7668. Drs Patel, Alspach, and Rabe offer the latest in periodontal services, dental implants and implantology, as well as specialized dentistry including Sedation. ROOT Periodontal & Implant Center is renowned for its excellent patient care and state-of-the-art dental technology to provide long-lasting results. "We are delighted to be expanding our services into Frisco. We believe our enormous experience, highly-skilled and dedicated team will make an active contribution to our patients' overall health," commented founder and lead periodontist Dr Amit M. Patel. "As crucial as teeth and oral health is, we also understand that patients have a busy life, which is why we are committed to making every visit to the clinic as efficient as possible. " He added: "If you have been diagnosed with periodontal disease and are prepared to take active steps to improve your oral health, we are here to provide you with the supports you deserve. "Because we take your health, confidence, and teeth seriously, we are deeply committed to helping you achieve and maintain that bright, healthy smile that you deserve." ROOT Periodontal & Implant Center also has clinics in Carrollton, Denton and Flower Mound. For further details on their services call them on 469-489-7668 or via their website https://www.rootdfw.com/frisco-tx/ (Added: Sat Sep 21 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• ROOT Periodontal & Implant Center Announces Addition of New Dentist - Carrollton, TX - September 21, 2019 - ROOT Periodontal & Implant Center has recruited a new dentist to its team - the award-winning Dr Laura N. Rabe. ROOT Periodontal and Implant Center is dedicated to identifying and addressing periodontal disease and providing personalized care programs for patients with services including regular maintenance and dental implants. Given the team's exceptional attention to detail and commitment to contributing to the client's overall health in a friendly environment, they are delighted to welcome Dr Rabe. Dr Rabe attended The University of Texas at Austin where she received her Bachelor's of Science in Human Development and Family Sciences. She then attended The University of Texas Health Science Center at Houston for her Doctor of Dental Surgery (DDS) degree. In Houston, she also received her Certificate for a speciality in Periodontics and her Master of Science in Dentistry (MSD). Dr Rabe is an active member of the American Dental Association and has held many leadership positions in this organization. She is also a member of The Texas Dental Association, The Dallas Dental Society and The American Academy of Periodontology. She received a national award for her research in dental implantology through the Academy of Osseointegration in 2019. Dr Rabe is proficient in dental surgical regeneration, dental implant placement, soft tissue grafting and the treatment of chronic and aggressive periodontal diseases. Her goals put the patient first and provide outstanding quality of care. She strives to deliver esthetic and functional results in a comfortable environment. Dallas-born Dr Rabe said: "I am excited to be practising periodontics in my home town." She currently lives in the Dallas area with her husband and their golden retriever, Stella. Her future goals include publishing dental research and practising part-time as a faculty at the Baylor School of Dentistry in Dallas. Serving the residents of the Greater Dallas area, ROOT Periodontal & Implant Center is renowned for its excellent patient care and state-of-the-art dental technology to provide long-lasting results. "In welcoming Dr Rabe, we believe she will add enormous experience to an already highly-skilled and dedicated team whose main mission is to make an active contribution to our patients' overall health," commented founder and lead periodontist Dr Amit M. Patel. "As crucial as teeth and oral health is, we also understand that patients have a busy life, which is why we are committed to making every visit to the clinic as efficient as possible. " Located at 2440 N. Josey Lane, Suite 202, appointments with the team or further details on their services can be made by phone on (972) 242-7603 or via their website https://www.rootdfw.com/carrollton-tx/ (Added: Sat Sep 21 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Smile Eden Prairie Welcomes New Dentist - Eden Prairie, MN - September 21, 2019 - Smile Eden Prairie is delighted to announce a new addition to their dental practice - Dr Sara Fam. The practice has built its experience on the foundation of providing the best compassionate dental care, delivered by a team who believe in comprehensive care and patient education. And Dr Fam fits that philosophy just like a glove! Dr Fam graduated from the University of Minnesota Dental school in 2011 and has since completed advanced training in implants with the Garg Implant Center in Miami. She is a member of a Spear Study Club where she continually improves her knowledge and skills. Active in the Minneapolis District Dental Society, and a member of ADA, and MDA, Dr Fam is also certified to offer full I.V. sedation. Dr Sara grew up in the Savage area, and attended St. John the Baptist grade school in Savage. Dentistry runs in Dr Sara's family as both of her sisters are also dentists, and she married a dentist! Dr Sara and her husband live in Bloomington and have a son, Victor. With such a family-focused, caring attitude, Dr Fam is delighted to be helping Smile Eden Practice to extend a welcoming hand to the broader community. The practise provides general and cosmetic dentistry to families and residents of Eden Prairie, Chanhassen, Shakopee, Minnetonka And Edina. Located at 6600 City W Pkwy #315 Eden Prairie, MN 55344, appointments with Dr Fam and the team can be made by phone on (952) 941-9829 or via their website https://www.smileedenprairie.com Their team are dedicated to top patient care and improving the patient experience in a welcoming and relaxing environment. Dental services include dental implants, extractions, root canal therapy, fillings, Invisalign, dental crowns, dentures, and more. "Our primary goal as a practitioner is to help people achieve optimal oral health outcomes," said practice founder Melissa Zettler. "We pride ourselves on providing a tranquil and serene environment with state-of-the-art dental technology, including digital x-rays and intra-oral cameras." The office also offers general dentistry solutions, including cleanings and dentures, as well as cosmetic dentistry to help patients improve the look of their smiles, such as teeth whitening and porcelain veneers. Smile Eden Prairie is also a member of the American Dental Association, Academy of General Dentistry and the Minnesota Dental Association. For more information about Smile Eden Prairie, visit https://www.smileedenprairie.com or call (952) 941-9829. (Added: Sat Sep 21 2019 Hits: 10 Rating: 0.00 Votes: 0) Rate It

• 5th International Heart Conference - With the success of its previous series, Organizing Committee of Advanced Heart 2019 is glad to invite all the cardiologists, research scholars, students and other academicians to the upcoming series Advanced Heart 2020. The conference is designed with a theme of “Experience an exponential advance in cardiac studies”. Advanced Heart 2020 includes 18 tracks designed to offer overarching sessions that address current issues in the field of Cardiology. This conference will provide an extensive update on all clinical, surgical, and interventional, topics in cardiology. Experts with national and international reputations in various fields will address the latest guidelines, therapeutic approaches, recent trends, etc., in cardiovascular medicine. Additionally, attendees will learn about recent trials being practiced that are likely to influence future practices. The areas of cardiology that will be covered are: Heart Disorders, Cardiovascular Diseases, Heart Failure, Cardiac surgery, Imaging, Heart health in women, recent research trends in Cardiology and many more. Target Audience: • Cardiologists • Academicians • Research Scholars • Industrial Professionals • Academic Scientists • Pharmacologists • Business Delegates • Medical Students • Laboratory Technicians • Sonographers • Postdoctoral fellows and trainees (Added: Sat Sep 21 2019 Hits: 14 Rating: 0.00 Votes: 0) Rate It

• 5th International Heart Conference - With the success of its previous series, Organizing Committee of Advanced Heart 2019 is glad to invite all the cardiologists, research scholars, students and other academicians to the upcoming series Advanced Heart 2020. The conference is designed with a theme of “Experience an exponential advance in cardiac studies”. Advanced Heart 2020 includes 18 tracks designed to offer overarching sessions that address current issues in the field of Cardiology. This conference will provide an extensive update on all clinical, surgical, and interventional, topics in cardiology. Experts with national and international reputations in various fields will address the latest guidelines, therapeutic approaches, recent trends, etc., in cardiovascular medicine. Additionally, attendees will learn about recent trials being practiced that are likely to influence future practices. The areas of cardiology that will be covered are: Heart Disorders, Cardiovascular Diseases, Heart Failure, Cardiac surgery, Imaging, Heart health in women, recent research trends in Cardiology and many more. Target Audience: • Cardiologists • Academicians • Research Scholars • Industrial Professionals • Academic Scientists • Pharmacologists • Business Delegates • Medical Students • Laboratory Technicians • Sonographers • Postdoctoral fellows and trainees (Added: Sat Sep 21 2019 Hits: 8 Rating: 0.00 Votes: 0) Rate It

• 5th International Heart Conference - With the success of its previous series, Organizing Committee of Advanced Heart 2019 is glad to invite all the cardiologists, research scholars, students and other academicians to the upcoming series Advanced Heart 2020. The conference is designed with a theme of “Experience an exponential advance in cardiac studies”. Advanced Heart 2020 includes 18 tracks designed to offer overarching sessions that address current issues in the field of Cardiology. This conference will provide an extensive update on all clinical, surgical, and interventional, topics in cardiology. Experts with national and international reputations in various fields will address the latest guidelines, therapeutic approaches, recent trends, etc., in cardiovascular medicine. Additionally, attendees will learn about recent trials being practiced that are likely to influence future practices. The areas of cardiology that will be covered are: Heart Disorders, Cardiovascular Diseases, Heart Failure, Cardiac surgery, Imaging, Heart health in women, recent research trends in Cardiology and many more. Target Audience: • Cardiologists • Academicians • Research Scholars • Industrial Professionals • Academic Scientists • Pharmacologists • Business Delegates • Medical Students • Laboratory Technicians • Sonographers • Postdoctoral fellows and trainees (Added: Sat Sep 21 2019 Hits: 6 Rating: 0.00 Votes: 0) Rate It

• Sarcoma patient was evacuated from Kolkata to Mumbai for better treatment by Global - 20 September 2019 Global Air Ambulance sifts the patient from one city to the other cities of India through commercial and private chartered aircraft. We transfer the patient through bed-to-bed service from one place to another. You can book our services through call and mail. We are available to you 24/7 for your help in case of emergency. Sarcoma: It is a type of cancer that forms in the bone and soft tissues including fat, blood vessels, muscles, fibrous tissue. Most common bone cancer is osteosarcoma. Global Air Ambulance from Kolkata had sifted the critical sarcoma patient in the presence of a doctor and with the help of paramedic team to the road ambulance through bed-to-bed service. Then our team had taken the patient with one attendant from the patient side to Kolkata Airport. Global Air Ambulance had sifted the patient to the privet charter aircraft which was fully equipped with the modern life-support tools. Throughout the journey, our medical team and MD doctors had taken care of the patient. Global Road Ambulance had taken the patient from Mumbai Airport to Tata memorial hospital, Mumbai. We take care of all the medicine and other health-related issues during travel very well. Global Air Ambulance in Raipur with specialized doctor paramedics and advance medical pieces of equipment like infusion pumps, cardiac monitor, ECG, invasive and non-invasive blood pressure, oxygen supplies, portable section units, FAA approved stretcher system, ventilator, defibrillator, infusion system, section machine, transport incubator, cardiac monitor, etc at the time of sifting. The costing of our services is very low and can be easily affordable by anybody. Global Air Ambulance also provides the service of Train and Road ambulance with all advance medical pieces of equipment, MD/MBBS doctor and paramedics at a very low-cost. We take proper care of hygiene and cleanness of the ambulance and other equipment's used. You can book our service s anytime from anywhere in India we will are available for you 24 hour. Web @ Global Air Ambulance in Patna specialized in providing evacuation service in economical price More @ https://www.globalairambulance.in/air-ambulance-services-in-raipur/ (Added: Fri Sep 20 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Blood Glucose Device Market, Users Global Forecast, SMBG Components, Countries & Companies - According to International diabetes federation, in 2017, there are around 425 million of people living with diabetes in the world. Diabetes people all over the world use glucose meter, test strips and lancing device to measure the blood glucose level. There are many diabetes patients especially insulin dependent that has severe hypoglycemic and hyperglycemic index level. They use 3-4 or even more than that strips on the daily basis to monitor the blood glucose level. As monitoring blood glucose is an essential part of diabetes management. Moreover, SMBG device are convenient to use at any point of time before breakfast, before meal, after meal and before –after exercise. According to Renub Research the Global Blood Glucose Device Market is expected to surpass US$ 20 Billion mark by the end of the year 2025. The SMBG market is growing with rapid pace due to numerous key factors like rising global diabetes population (type 1 diabetes and type 2 diabetes), increasing insulin dependent diabetes population, increasing obese population, rise in ageing population, rising awareness regarding diabetes and technological advancement of SMBG device that makes convenience for patient to easily measure blood glucose level. China has the Highest Diabetes Population in the World Diabetes prevalence in China has been growing with rapid pace and it become one of the largest diabetes country in the world. Nearly 114 million people affected with diabetes in China but the prevalence of SMBG user in China was quite low as compared to developed countries. Changing lifestyle and food habits is the key reason to increase diabetes population in China. Access full Research: https://www.renub.com/blood-glucose-device-market-and-forecast-smbg-test-strips-lancet-meter-worldwide-analysis-977-p.php In this report, we have taken diabetes population of 17 countries; United States, United Kingdom, India, Netherlands, Germany, Australia, Spain, Russia, Brazil, Kuwait, Switzerland, China, Italy, Norway, Sweden, South Africa and Saudi Arabia etc. here we have fragmented diabetes population of each country into two parts; Type 1 Diabetes and Type 2 Diabetes. Self-Monitoring Blood Glucose Devices Insight In this report, we have done comprehensive analysis of SMBG user like; their frequency of utilizing test-strips, its market and number of people that uses device. SMBG is mainly used by type 1 diabetes population and insulin user of type 2 diabetes to monitor their blood glucose. In addition, the people those are facing hypoglycemia and hyperglycemia are also frequent user of SMBG device. In this report, we have divided SMBG user into two parts; type 1 diabetes user and type 2 diabetes users. Here SMBG report constitutes three components; Test Strips, Lancet Device and Glucose Meter. Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=blood-glucose-device-market-and-forecast-smbg-test-strips-lancet-meter-worldwide-analysis-977-p.php Blood Glucose Device Market - 17 Countries Covered in this Report: America 1. United States 2. Brazil Europe 3. United Kingdom 4. Germany 5. Spain 6. Italy 7. Netherlands 8. Norway 9. Sweden 10. Switzerland 11. Russia Asia & Pacific 12. India 13. China 14. Australia Middle East & Africa 15. Kuwait 16. Saudi Arabia 17. South Africa “Blood Glucose Device Market, Users Global Forecast, SMBG Components (Test Strips, Lancet, Meter) of 17 Countries (USA, Europe, Asia & Pacific, Middle East & Africa) & Companies (Roche, LifeScan Inc. Bayer HealthCare, Abbott)” analyzes the worldwide market for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market. This is the 5th publication on Blood Glucose Device Market by Renub Research. This report studies the separate comprehensive analytics for the 17 countries: United States, European Countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden and Switzerland), BRIC countries (Brazil, Russia, India, China), Australia and Kuwait. Annual estimates and forecast are provided for the period of 2019 through 2025. A six year historic analysis is also provided for these markets. Company Analysis 1. Roche Diagnostic 2. LifeScan Inc., 3. Bayer HealthCare 4. Abbott Laboratories All the 4 Companies Studied in the Report have been Studied from 3 Points • Company Overview • Recent Developments • Financial Insight If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team. Contact Us Email: info@renub.com Phone: +1-678-302-0700 Web: www.renub.com (Added: Fri Sep 20 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Lateral Flow Assay Market Global Trends, Market Share, Industry Size, Growth - Global lateral flow assay market envisioned to value over US$ 9.7 Billion by 2029 end and register a CAGR of over 6.9% from 2019 to 2029. Lateral flow assay is used to ratify pathogens or biomarkers in animals and humans. It's mostly used in human health and in medical diagnostics for laboratory use and home testing. Increase in disposable income and rising geriatric population are expected to fuel the growth of the market. Increase demand for home pregnancy tests is also boosting the growth of the market. The market is bifurcated on the basis of the product type, indications and distribution channel. On product type, the market is segmented into Readers and LFA Kits. Readers consist of handheld readers & bench top readers. A gradual increase in miniaturization has enhanced the preference of handheld readers. Latest advancements in technology are expected to create more demand for bench top readers. Advancement of technology is expected to create more demand for mobile readers. LFA kits consist of a test strip, dipstick, cassette & lancets. Rising demand for test strip among consumers is expected to inflate the size of the market during the forecast period. Based on indications, the market is segmented into infectious diseases, pregnancy, and drug abuse testing. Infectious diseases consist of mosquito-borne diseases, streptococcus infections, sexually transmitted infections (STI), hepatitis, tuberculosis (TB), gastrointestinal infections & others. Increasing prevalence regarding mosquito-borne diseases is stimulating the growth of the market. Based on the distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, supermarket/hypermarket & e-commerce. Retail pharmacies are currently dominating the market. However, e-commerce is expected to grow during the forecast period. However, time consuming and strict policies coupled with the inconsistency of test results are expected to hinder the growth of the market. Based on geographical regions, North America accounts for the largest share of the market. Increasing prevalence of infectious diseases coupled with a rise in demand of handheld readers remain the key factors driving the growth of the market in the region. Europe is followed after North America. Asia-Pacific region is witnessed to see huge growth of the market during the forecast period. Factors such as large population and increasing government initiatives to support health care facilities are expected to propel the growth of the market in the region. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=260&page=requestsample Global Lateral Flow Assay Market Segmentation: By Product Type • Readers o Bench top readers o Handheld readers • LFA Kits o Test strip o Dipstick o Cassette o Lancets By Indications • Infectious Diseases i. Mosquito-borne Diseases ii. Streptococcus Infections iii. Sexually transmitted infections (STI) iv. Hepatitis v. Tuberculosis (TB) vi. Gastrointestinal Infections vii. Others • Pregnancy Test • Drug of Abuse Testing By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Supermarket/Hypermarket • E-commerce By Region: • Europe • North America • APAC • Latin America • Rest of World Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=260&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the lateral flow assay market based on the product type, indications, distribution channel, and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents Lateral Flow Assay Market: Global Industry Analysis & Forecast 2019–2029 1. Market Introduction 2.1. Market Definition 2.2. Market Taxonomy 2. Executive Summary 1.1. Market Overview 1.2. Market Analysis 3. Market Background 4.1. Market Evolution 4.2. Market Dynamics 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Trends 4. Lateral Flow Assay Market Size (US$ Mn) & Volume Trend Analysis by Product Type, 2014–2018 • Readers • Bench top Readers • Handheld Readers • LFA Kits o Test strip o Dipstick o Cassette o Lancets 5. Lateral Flow Assay Market Size (US$ Mn) Trend Analysis by Indications, 2014–2018 Infectious Diseases o Mosquito-borne Diseases o Streptococcus Infections o Sexually transmitted infections (STI) o Hepatitis o Tuberculosis (TB) o Gastrointestinal Infections o Others Pregnancy Test Drug of Abuse Testing Market Size (US$ Mn) Forecast By Indications, 2019–2029 6. Lateral Flow Assay Market Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2014–2018 o Hospital Pharmacies o Retail Pharmacies o Supermarket/Hypermarket o E-Commerce Market Size (US$ Mn) Forecast By Distribution Channel, 2019–2029 7. North America Lateral Flow Assay Market Analysis 2014–2018 and Forecast 2019–2029 7.1. Introduction 7.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2014–2018 7.2.1. U.S. 7.2.2. Canada 8. Latin America Lateral Flow Assay Market Analysis 2014–2018 and Forecast 2019–2029 8.1. Introduction 8.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2014–2018 8.2.1. Brazil 8.2.2. Mexico 8.2.3. Argentina 8.2.4. Rest of Latin America 9. Europe Lateral Flow Assay Market Analysis 2014–2018 and Forecast 2019–2029 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2014–2018 9.2.1. Germany 9.2.2. U.K. 9.2.3. France 9.2.4. Italy 9.2.5. Spain 9.2.6. Russia 9.2.7. Rest of Europe 10. Asia-Pacific Lateral Flow Assay Market Analysis 2014–2018 and Forecast 2019–2029 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2014–2018 10.2.1. Japan 10.2.2. India 10.2.3. Australia and New Zealand 10.2.4. ASEAN 10.2.5. Rest of Asia-Pacific 10.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2019–2029 10.10. Market Attractiveness Analysis 10.10.1. By Country 10.10.2. By Product Type 10.10.3. By Indications 10.10.4. By Distribution Channel 10.11. Drivers and Restraints: Impact Analysis 11. Middle East & Africa Lateral Flow Assay Market Analysis 2014–2018 and Forecast 2019–2029 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2014–2018 11.2.1. GCC Countries 11.2.2. South Africa 11.2.3. Rest of MEA 12. Market Structure Analysis 13. Competition Landscape • Abbott Laboratories • BioMerieux S.A • Bio-Rad Laboratories Inc. • Danaher Corporation • QIAGEN N.V. • Thermo Fisher Scientific, Inc. • Siemens Healthineers • Hologic Inc. • F. Hoffmann-La Roche Ltd Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Fri Sep 20 2019 Hits: 27 Rating: 0.00 Votes: 0) Rate It

• Hydrogen Breath Test Analyzer Market Global Trends, Market Share - Global Hydrogen Breath Test Analyzer Market Introduction: Global Hydrogen Breath Test Analyzer Market is estimated to value over USD 37 Million by 2029 end and register a CAGR of over 3.5% during the forecast period, 2019 to 2029. The number of patients suffering from gastrointestinal disorders is on a rise owing to unhealthy diet choices and a sedentary, stressful life. According to a survey conducted by the World Gastroenterology Organization, 15% to 25% of the world population suffer from gastroesophageal reflux disease (GERD). The prevalence of this disease is the highest in the U.S with around 26%, Norway and Sweden have around 25% prevalence. The rise in the number of gastrointestinal disorder patients across the world has resulted in the growth of the market. Global Hydrogen Breath Test Analyzer Market Overview: Based on the type of product, the global market is bifurcated into portable hydrogen breath analyzer and handheld hydrogen breath analyzer. The handheld analyzer is slowly gaining recognition among the patient population owing to its user-friendly nature, the expeditious analysis of exhaled air that it offers and its compactness. Depending on the type of sensor, the market is categorised as an electrochemical sensor and solid state sensor. Solid-state sensors are slowly gaining popularity owing to its non-intrusive nature of measuring gas from the breath that is exhaled. Therefore, this market segment is predicted to gain gradual traction during the forecast period. End-user wise, the market is segmented into hospitals, pediatric clinics, outpatient centres and diagnostic laboratories. Global Hydrogen Breath Test Analyzer Market Regional Insight: The European region holds around 33% of the total market share and it is anticipated to acquire more share of the market during the forecast period owing to a noteworthy rise in patients who are diagnosed with SIBO disorder and collaborations between medical device manufacturers and academic research in order to develop breath analyzers with excellent ergonomic features. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=255&page=requestsample Global Hydrogen Breath Test Analyzer Market Segmentation: 1. By Region • North America • Europe • Asia Pacific • Latin America 2. By Product Type • Portable Hydrogen Breath Analyzer • Handheld Hydrogen Breath Analyzer 3. By Sensor Type • Electrochemical Sensor • Solid State Sensor 4. By End User • Hospitals • Pediatric Clinics • Outpatient Centers • Diagnostic Laboratories Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=255&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global hydrogen breath test analyzer market by region, by product type, by sensor type and by end user • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and Latin America • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1. Market Introduction • Market Definition • Market Taxonomy • Inclusion and Exclusion 2. Executive Summary • Market Overview • Market Analysis 3. Hydrogen Breath Test Analyzer Market Opportunity Analysis • Macro-Economic Factors • Opportunity Analysis 4. Market Dynamics • Drivers • Restraints 5. Market Analysis By Product Type • Historical Market Size (US$ Mn) & Trend Analysis By Product Type, 2014–2018 • Portable Hydrogen Breath Analyzer • Handheld Hydrogen Breath Analyzer • Accessories and Consumables • Market Size (US$ Mn) & Volume (Unit) Forecast By Product Type, 2019–2029 6. Market Analysis by Sensor type - Size (US$ Mn) Trend Analysis By Sensor Type, 2014–2018 • Electrochemical Sensor • Solid state sensor • Market Size (US$ Mn) Forecast By Sensor Type, 2019–2029 7. Market Analysis by End User- Market Size (US$ Mn) Trend Analysis By End User, 2014–2018 • Hospitals • Pediatric Clinics • Outpatient Centers • Diagnostic Laboratories • Market Size (US$ Mn) Forecast By End User, 2019–2029 8. North America Hydrogen Breath Test Analyser Market Analysis 2014–2018 and Forecast 2019–2029 • Introduction • Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018 • U.S. • Canada • Market Size (US$ Mn) Forecast By Country, 2019–2029 9. Europe Hydrogen Breath Test Analyser Market Analysis 2014–2018 and Forecast 2019–2029 • Introduction • Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018 • Germany • U.K. • France • Italy • Spain • Russia • Rest of Europe 10. Latin America Hydrogen Breath Test Analyzer Market Analysis 2014–2018 and Forecast 2019–2029 • Introduction • Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018 • Brazil • Mexico • Rest of Latin America 11. Asia Pacific Hydrogen Breath Test Analyzer Market Analysis 2014–2018 and Forecast 2019–2029 • Introduction • Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018 • India • Japan • China • ASEAN • Australia and NZ • Rest of Asia Pacific 12. Competition Landscape • Bedfont Scientific Ltd. • QuinTron Instrument Company, Inc. • MD Diagnostics Ltd • LABORIE • FAN GmbH Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Fri Sep 20 2019 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• Histopathology Testing Equipment Market Global Trends, Market Share, Industry Size, Growth - Global histopathology testing equipment market is envisioned to value over US$ 8 Billion by 2029 end and register a CAGR of over 4% from 2019 to 2029. Histopathology is the perusal of tissues from the body with the help of a microscope and the signs and characteristics of the disease can be spotted. The histopathology testing equipment tools are utilized for the perusal of tissues and preparing samples. The American Cancer Society and National Center for Health Statistics have revealed that the cancer cases in the United States have crossed 1,685,000 in 2017 and the cases are likely to increase in the coming years. The rising cancer incidences have led to more demand for histopathology testing equipment market. Growing cases of cancer and associated mortalities have led to more demand for efficient tissue diagnosis. Rising demand less-invasive diagnostic procedures for cancer are inflating the size of the market. The rising geriatric population has been associated with diseases and chronic disorders have also pushed more demand for histopathology testing equipment. The market is bifurcated on the basis of product type, by application, by the end user, and by region. The product is further divided into instruments and consumables. Instruments consist of tissue processor equipment, tissue embedding equipment, cover slipper systems, microscopes, microtome & cryostat, and others. The consumables segments consist of reagents & antibodies, probes, kits, others. The rising demands for reagents and antibodies are fueling the growth of the market. Kits and reagents are predicted to contribute to the growth of the market during the forecast. Agilent Technologies Inc., acquired Multiplicom NV in 2017 to strengthen it's market presence in histopathology testing equipment market to hold Multiplcom's advanced diagnostic kits. Kits are required in high number for sequencing and diagnosing of chronic diseases. The application is segmented into drug discovery, disease diagnosis, research application. Disease diagnosis is contributing to the histopathology testing equipment. Research application is also witnessed to dominate the growth of the market in the coming years. In terms of end user, the market is segmented into hospital-based laboratories, diagnostic centres, and research organizations. Hospital-based laboratories are expected to control the growth of the market during the forecast period. In terms of region, North America regions have emerged as the largest market. Growing incidence of cancer and other diseases coupled with the presence of developed healthcare infrastructure has fueled the growth of the market in the region. Asia-Pacific region is forecasted to be a lucrative region for the manufacturers. The rapid development of healthcare infrastructure, technological advancements, and the rising prevalence of cancer and other chronic diseases have spurred the size of the market in the region. Key players of the market are Thermo Fisher Scientific, Advanced Cell Diagnostics Inc, Abbott Laboratories, Abcam, Omnyx, Monogram Biosciences, Sakura Fintek, and others. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=269&page=requestsample Global Histopathology Testing Equipment Market Segmentation By Product Type 1. Instruments a. Tissue Processor Equipment ➢ Automatic ➢ Manual b. Tissue Embedding Equipment c. Slide Strainers Systems ➢ High-throughput Strainers ➢ Compact Strainers d. Cover slipper Systems ➢ Fully automated cover slipping workstation ➢ Flexible cover slipping workstation e. Microtome & Cryostat ➢ Rotatory/Manual Microtome ➢ Semi-Automatic Microtome ➢ Fully Automatic Microtome ➢ Manual Cryostat ➢ Fully Automatic Cryostat ➢ Semi-Automatic Cryostat f. Microscopes g. Other Instruments 2. Consumables a. Reagents & antibodies b. Probes c. Kits d. Other consumables By Application • Drug Discovery • Disease Diagnosis • Research Application By End Users • Hospital-based laboratories • Diagnostic Centers • Research Organizations By Region: • Europe • North America • APAC • Latin America • Rest of World Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=269&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the histopathology testing equipment market based on the product type, by application, by end users, and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Fri Sep 20 2019 Hits: 18 Rating: 0.00 Votes: 0) Rate It

• Cell Isolation or Cell Separation Market Global Trends, Market Share - Cell Isolation or Cell Seperation Market to value over USD 14 billion and register a CAGR of over 16.1% during the forecast period of 2019 to 2026. The cell isolation market is a market that augmenting at a bolstering rate. The market is primarily driven by initiatives undertaken to promote research and development by the companies which focus on innovating novel treatment for incurable diseases like cancer. Moreover, the rising trend of stem cell isolation in developing countries is also expected to augment the cell isolation market in the near future. Similarly, increased government funding for cell-based research globally and a rising preference for personalized medicines would spur the cell isolation market growth. Based on the product, the market is segmented into consumables and instruments. Increasing investments to promote research & development by biotechnology and biopharmaceutical companies is a principal factor boosting the segment growth. The demand for cell separation consumables is predicted to grow at a healthy CAGR during the forecast period. The instruments segment is projected to grow at a lucrative rate due to product expansion and portfolios. The technological advancement in instruments provides efficient cell separation in research, diagnostics, and therapeutics application. By cell type, the cell isolation market is segmented into human cells and animal cells. The growing focus on cancer & human stem cell research; and wide application of isolated human cells in research, biopharmaceuticals development, and clinical trials are the major factors contributing to the cell isolation market share. The animal type segment is expected to exhibit a significant growth rate during the study period. The drug discovery and development involves the use of animal cells to examine preliminary toxicity, efficacy, and pharmacokinetics of a new drug molecule. Based on the technique, the cell isolation/cell separation market is segmented into centrifugation, surface marker, and filtration. Surface marker and filtration segments are expected to showcase significant growth during the forecast period. Product advancement and growing investment in manufacturing infrastructure by companies are prime factors endorsing the growth of this segment. The manufacturers are using advanced filtration systems surface marker for the research and production process to assure the better quality of the end product. Based on end-users, the cell isolation market is segmented into research laboratories & institutes, hospitals & diagnostic laboratories, biotechnology & biopharmaceutical companies. The support of the government for cell-based research propels the segment growth. Prominent players in the market include Thermo Fisher Scientific, Inc., Merck KGaA; BD Biosciences, Beckman Coulter, Inc., Terumo BCT, GE Healthcare and STEMCELL Technologies Inc. Competitive Landscape ● Beckman Coulter launched CytoFLEX Flow Cytometry to increase product portfolio and establish a strong foothold in the market ● Miltenyi Biotec launched MultiMACS X Device to increase market services and offer advanced technology Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3371&page=requestsample Cell Isolation/Cell Separation Market Segmentation: By Product ● Consumables ■ Reagents, kits, media, and sera ■ Beads ■ Disposables ● Instruments ■ Centrifuges ■ Flow cytometers ■ Filtration systems ■ Magnetic-activated cell separator systems By Cell Type ● Human cells ● Animal cells By Technique ● Centrifugation ● Surface marker ● Filtration By Application ● Biomolecule isolation ● Cancer research ● Stem cell research ● Tissue regeneration ● In vitro diagnostics ● Therapeutics By End-Use ● Research laboratories and institutes ● Hospitals and diagnostic laboratories ● Cell banks ● Biotechnology and biopharmaceutical companies By Region: ● Europe ● North America ● APAC ● Latin America ● Rest of World Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3371&page=askfordiscount Competitive Landscape: ● Tier 1 players- established companies in the market with a major market share ● Tier 2 players ● Emerging players which are growing rapidly ● New Entrants FutureWise Takeaways ● Growth prospects ● SWOT analysis ● Key trends ● Key data points affecting market growth Objectives of the Study: ● To provide an exhaustive analysis on the global cell isolation/cell separation market by product, by cell type, by application,by technique, by end-user, and by region ● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ● To evaluate and forecast micro-markets and the overall market ● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world ● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions ● Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents Chapter 1 Research Methodology 1.1 Country wise market: Base estimates 1.2 Global market: CAGR calculation 1.3 Region based segment share calculation 1.4 Research scope & assumptions 1.5 List of data sources 1.5.1 Data for primary interviews, by sources 1.5.2 Data for primary interviews, by region Chapter 2 Executive Summary 2.1 Market snapshot Chapter 3 Cell Isolation/Cell Separation Market Variables, Trends & Scope 3.1 Market segmentation & scope 3.2 Market driver analysis 3.2.1 Rising demand for for biopharmaceuticals 3.2.2 Increasing government funding for cell-based research 3.2.3 Growing focus on personalized medicine 3.3 Market restraint analysis 3.3.1 Stringent government regulations 3.4 Key opportunities prioritized 3.4.1 Key opportunities prioritized, by product 3.4.2 Key opportunities prioritized, by cell type 3.4.3 Key opportunities prioritized, by technique 3.4.4 Key opportunities prioritized, by application 3.4.5 Key opportunities prioritized, by end-user 3.5 Cell isolation/cell separation- SWOT analysis, by factor (political & legal, economic and technological) 3.6 Industry analysis - Porter’s 3.7 Competitive landscape: Market position analysis, 2016 Chapter 4 Cell Isolation/Cell Separation: Product Estimates & Trend Analysis 4.1 Cell isolation/cell separation market: Product movement analysis 4.2 Consumables 4.2.1 Consumables market, 2014 - 2026 (USD Million) 4.2.2 Reagents, kits, media, and sera 4.2.2.1 Reagents, kits, media, and sera market, 2014 - 2026 (USD Million) 4.2.3 Beads 4.2.3.1 Beads market, 2014 - 2026 (USD Million) 4.2.4 Disposables 4.2.4.1 Disposables market, 2014 - 2026 (USD Million) 4.3 Instruments 4.3.1 Instruments market, 2014 - 2026 (USD Million) 4.3.2 Centrifuges 4.3.2.1 Centrifuges market, 2014 - 2026 (USD Million) 4.3.3 Flow cytometers 4.3.3.1 Flow cytometers market, 2014 - 2026 (USD Million) 4.3.4 Filtration systems 4.3.4.1 Filtration systems market, 2014 - 2026 (USD Million) 4.3.5 Magnetic-activated cell separator systems 4.3.5.1 Magnetic-activated cell separator systems market, 2014 - 2026 (USD Million) Chapter 5 Cell Isolation/Cell Separation: Cell Type Estimates & Trend Analysis 5.1 Cell isolation/cell separation market: Cell type movement analysis 5.2 Human cells 5.2.1 Human cells market, 2014 - 2026 (USD Million) 5.3 Animal cells 5.3.1 Animal cells market, 2014 - 2026 (USD Million) Chapter 6 Cell Isolation/Cell Separation Market: Technique Estimates & Trend Analysis 6.1 Cell isolation/cell separation market: Technique movement analysis 6.2 Centrifugation 6.2.1 Centrifugation market, 2014 - 2026 (USD Million) 6.3 Surface marker 6.3.1 Surface marker market, 2014 - 2026 (USD Million) 6.4 Filtration 6.4.1 Filtration market, 2014 - 2026 (USD Million) Chapter 7 Cell Isolation/Cell Separation: Application Estimates & Trend Analysis 7.1 Cell isolation/cell separation market: Application movement analysis 7.2 Biomolecule isolation 7.2.1 Biomolecule isolation market, 2014 - 2026 (USD Million) 7.3 Cancer research 7.3.1 Cancer research market, 2014 - 2026 (USD Million) 7.4 Stem cell research 7.4.1 Stem cell research market, 2014 - 2026 (USD Million) 7.5 Tissue regeneration 7.5.1 Tissue regeneration market, 2014 - 2026 (USD Million) 7.6 In vitro diagnostics 7.6.1 In vitro diagnostics market, 2014 - 2026 (USD Million) 7.7 Therapeutics 7.7.1 Therapeutics market, 2014 - 2026 (USD Million) Chapter 8 Cell Isolation/Cell Separation: End-Use Estimates & Trend Analysis 8.1 Cell isolation/cell separation market: End-use movement analysis 8.2 Research laboratories and institutes 8.2.1 Research laboratories and institutes market, 2014 - 2026 (USD Million) 8.3 Hospitals and diagnostic laboratories 8.3.1 Hospitals and diagnostic laboratories market, 2014 - 2026 (USD Million) 8.4 Cell banks 8.4.1 Cell banks market, 2014 - 2026 (USD Million) 8.5 Biotechnology and biopharmaceutical companies 8.5.1 Biotechnology and biopharmaceutical companies market, 2014 - 2026 (USD Million) Chapter 9 Cell Isolation/Cell Separation: Regional Estimates & Trend Analysis, by Product, Cell Type, Technique, Application, End Use 9.1 Cell isolation/cell separation market share by region, 2016 & 2025 9.2 North America 9.2.1 U.S. 9.2.1.1 U.S. cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.2.1.2 U.S. cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.2.1.3 U.S. cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.2.1.4 U.S. cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.2.1.5 U.S. cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.2.2 Canada 9.2.2.1 Canada cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.2.2.2 Canada cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.2.2.3 Canada cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.2.2.4 Canada cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.2.2.5 Canada cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.3 Europe 9.3.1 Germany 9.3.1.1 Germany cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.3.1.2 Germany cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.3.1.3 Germany cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.3.1.4 Germany cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.3.1.5 Germany cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.3.2 UK 9.3.2.1 UK cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.3.2.2 UK cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.3.2.3 UK cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.3.2.4 UK cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.3.2.5 UK cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.4 Asia Pacific 9.4.1 Japan 9.4.1.1 Japan cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.4.1.2 Japan cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.4.1.3 Japan cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.4.1.4 Japan cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.4.1.5 Japan cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.4.2 China 9.4.2.1 China cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.4.2.2 China cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.4.2.3 China cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.4.2.4 China cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.4.2.5 China cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.4.3 India 9.4.3.1 India cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.4.3.2 India cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.4.3.3 India cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.4.3.4 India cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.4.3.5 India cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.5 Latin America 9.5.1 Brazil 9.5.1.1 Brazil cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.5.1.2 Brazil cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.5.1.3 Brazil cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.5.1.4 Brazil cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.5.1.5 Brazil cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.5.2 Mexico 9.5.2.1 Mexico cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.5.2.2 Mexico cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.5.2.3 Mexico cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.5.2.4 Mexico cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.5.2.5 Mexico cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) 9.6 MEA 9.6.1 South Africa 9.6.1.1 South Africa cell isolation/cell separation market, by product, 2014 - 2026 (USD Million) 9.6.1.2 South Africa cell isolation/cell separation market, by cell type, 2014 - 2026 (USD Million) 9.6.1.3 South Africa cell isolation/cell separation market, by technique, 2014 - 2026 (USD Million) 9.6.1.4 South Africa cell isolation/cell separation market, by application, 2014 - 2026 (USD Million) 9.6.1.5 South Africa cell isolation/cell separation market, by end-use, 2014 - 2026 (USD Million) Chapter 10 Competitive Landscape 10.1 Company Profiles 10.1.1 Thermo Fisher Scientific, Inc. 10.1.1.1 Company overview 10.1.1.2 Financial performance 10.1.1.3 Product benchmarking 10.1.1.4 Strategic initiatives 10.1.2 Merck KGaA 10.1.2.1 Company overview 10.1.2.2 Financial performance 10.1.2.3 Product benchmarking 10.1.2.4 Strategic initiatives 10.1.3 BD Biosciences 10.1.3.1 Company overview 10.1.3.2 Financial performance 10.1.3.3 Product benchmarking 10.1.3.4 Strategic initiatives 10.1.4 Beckman Coulter, Inc. 10.1.4.1 Company overview 10.1.4.2 Financial performance 10.1.4.3 Product benchmarking 10.1.4.4 Strategic initiatives 10.1.5 Terumo BCT 10.1.5.1 Company overview 10.1.5.2 Financial performance 10.1.5.3 Product benchmarking 10.1.5.4 Strategic initiatives 10.1.6 GE Healthcare 10.1.6.1 Company overview 10.1.6.2 Financial performance 10.1.6.3 Product benchmarking 10.1.6.4 Strategic initiatives 10.1.7 STEMCELL Technologies Inc. 10.1.7.1 Company overview 10.1.7.2 Financial performance 10.1.7.3 Product benchmarking 10.1.7.4 Strategic initiatives 10.1.8 Bio-Rad Laboratories, Inc. 10.1.8.1 Company overview 10.1.8.2 Financial performance 10.1.8.3 Product benchmarking 10.1.8.4 Strategic initiatives 11. Assumptions and Acronyms 12. Research Methodology 13. List of Sources of Information (Primary and Secondary) Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Fri Sep 20 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Biodegradable Cosmetic Packaging Market Global Trends, Market Share - Alarming environmental conditions, legal enforcements towards using bio-degradable packaging materials over hazardous conventional materials in various countries, increase in demand and supply of cosmetic and skin care products, and the advent of 3D printing for superior branding schemes, are the key market drivers of the biodegradable cosmetic packaging market. The global biodegradable cosmetic packaging market is estimated to outstrip the global value of $7 billion by 2026 end. The cosmetic packaging requires both primary packaging for containment and safety of the cosmetic product and secondary packaging for the brand perception. The biodegradable cosmetic packaging can be in the form of bottles, pouches, jars, tubes and containers. Biodegradable packaging material is derived from organic sources like corn-starch/soya, refined mineral ores of aluminium and rust free metals like silver as these substances can easily be decomposed in a nature-friendly way, minimize the efforts of waste management and reduce the landfills issue. Sustainable biodegradable cosmetic packaging materials will draw substantial traction in the global biodegradable cosmetic packaging market in coming years. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=68&page=requestsample Global Biodegradable Cosmetic Packaging, by Product Type • Bottles • Pouches • Jars • Tubes • Containers Global Biodegradable Cosmetic Packaging, by Material • PIR (Post-Industrial Recycled) • PCR (Post-Consumer Recycled) • Paperboard • Others Sustainable packaging options like PIR and PCR are trending as it saves the significant cost of manufacturing the structured packaging from scratch apart from reducing the carbon footprint. Although PCR may not be perceived as a major segment enabling cost saving as compared to PIR, it for sure provides a significant mileage as a market differentiator. PIR is anticipated to continue gaining rapid market share followed by PCR during the forecast period, 2019-2026. In lieu of green product purchasing trend, PCR might soon become a novel genesis for market entry. Global Biodegradable Cosmetic Packaging, by Region: • Europe • North America • APAC • Latin America • Rest of World Global Biodegradable Cosmetic Packaging market is dominated by North America and Europe region due to high penetration over the general population. U.S. account major share in the North America market and Europe is dominated by UK, France and Germany due to high awareness and demand for green products. The Asia Pacific & Lain America regions have created a potential opportunistic space for manufacturers due to the increasing importance of environmental protection. Countries such as China, Japan and India, promote the use of biodegradable materials and there is an increase in initiatives by the governments promoting the use of sustainable packaging materials. Rest of the world is expected to account a notable share in the global biodegradable cosmetic packaging market due to progressing adoption. Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=68&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global biodegradable cosmetic packaging, by product type, by material, by end-user, and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1. Introduction 1.1. Scope and Objective 1.2. Assumptions and Acronyms 1.3. Forecast Factors 1.4. Research Methodology 2. Executive Summary 2.1. Industry Cluster Analysis 2.2. Competition Matrix 2.3. Strategies Recommendations 3. Market Definition 3.1. Report Scope (Inclusions & Exclusions) 3.2. Market Segmentation 4. Global Biodegradable Cosmetic Packaging Market Overview 4.1. Global Biodegradable Cosmetic Packaging Market Revenue (USD Mn) 4.2. Regional Average Selling Pricing Analysis (USD), By Product Type, 2018 5. Key Inclusions 5.1. Porter’s Five Force analysis 5.2. Market Dynamics 5.3. Industry Trends 5.4. Regulatory Guidelines 5.5. Opportunities in Biodegradable Cosmetic Packaging 6. Competition Dynamics 6.1. Company Share Analysis (2018) 6.2. Top 10 Product Pricing by Region 7. Global Biodegradable Cosmetic Packaging Market Revenue (USD Mn), 2018-2026 by Product Type 7.1. Key Market Findings 7.2. Long Term ROI Segments 7.3. Revenue Opportunity Influencing Factors 7.4. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 7.4.1 Bottles 7.4.2 Pouches 7.4.3 Jars 7.4.4 Tubes 7.4.5 Containers 8. Global Biodegradable Cosmetic Packaging Market Revenue (USD Mn), 2018-2026 by Material 8.1. Key Market Findings 8.2. Long Term ROI Segments 8.3. Revenue Opportunity Influencing Factors 8.4. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026 8.4.1 PIR 8.4.2 PCR 8.4.3 Paperboard 8.4.4 Others 9. Global Biodegradable Cosmetic Packaging Market Revenue (USD Mn), 2018-2026 by Region 9.1. Key Market Findings 9.2. Long Term ROI Segments 9.3. Revenue Opportunity Influencing Factors 9.4. Market Revenue (USD Mn) Assessment and Forecast by Region,2026 9.4.1 North America 9.4.2 Latin America 9.4.3 Europe 9.4.4 Asia Pacific 9.4.5 Rest of world 10. North America Biodegradable Cosmetic Packaging Market Revenue (US$ Mn), 2018-2026 10.1. Key Market Findings 10.2. Long Term ROI Segments 10.3. Revenue Opportunity Influencing Factors 10.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 10.4.1 US 10.4.2 Canada 10.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 10.5.3 Bottles 10.5.4 Pouches 10.5.5 Jars 10.5.6 Tubes 10.5.7 Containers 10.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026 10.6.8 PIR 10.6.9 PCR 10.6.10 Paperboard 10.6.11 Others 11. Latin America Biodegradable Cosmetic Packaging Market Revenue (US$ Mn), 2018-2026 11.1. Key Market Findings 11.2. Long Term ROI Segments 11.3. Revenue Opportunity Influencing Factors 11.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 11.4.1 Brazil 11.4.2 Mexico 11.4.3 Argentina 11.4.4 Rest of Latin America 11.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 11.5.5 Bottles 11.5.6 Pouches 11.5.7 Jars 11.5.8 Tubes 11.5.9 Containers 11.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026 11.6.10 PIR 11.6.11 PCR 11.6.12 Paperboard 11.6.13 Others 12. Europe America Biodegradable Cosmetic Packaging Market Revenue (US$ Mn), 2018-2026 12.1. Key Market Findings 12.2. Long Term ROI Segments 12.3. Revenue Opportunity Influencing Factors 12.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 12.4.1 Germany 12.4.2 France 12.4.3 Spain 12.4.4 UK 12.4.5 Russia 12.4.6 Poland 12.4.7 Rest of Europe 12.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 12.5.8 Bottles 12.5.9 Pouches 12.5.10 Jars 12.5.11 Tubes 12.5.12 Containers 12.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026 12.6.13 PIR 12.6.14 PCR 12.6.15 Paperboard 12.6.16 Others 13. Asia Pacific America Biodegradable Cosmetic Packaging Market Revenue (US$ Mn), 2018-2026 13.1. Key Market Findings 13.2. Long Term ROI Segments 13.3. Revenue Opportunity Influencing Factors 13.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 13.4.1 Emerging Asia 13.4.1.1 China 13.4.1.2 India 13.4.1.3 ASEAN-5 13.4.1.4 Rest of Emerging Asia 13.4.2 Japan 13.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 13.5.3 Bottles 13.5.4 Pouches 13.5.5 Jars 13.5.6 Tubes 13.5.7 Containers 13.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026 13.6.8 PIR 13.6.9 PCR 13.6.10 Paperboard 13.6.11 Others 14. Rest of World America Biodegradable Cosmetic Packaging Market Revenue (US$ Mn), 2018-2026 14.1. Key Market Findings 14.2. Long Term ROI Segments 14.3. Revenue Opportunity Influencing Factors 14.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 14.4.1 Middle East 14.4.2 South Africa 14.4.3 North Africa 14.4.4 Rest of World 14.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 14.5.5 Bottles 14.5.6 Pouches 14.5.7 Jars 14.5.8 Tubes 14.5.9 Containers 14.6. Market Revenue (USD Mn) Assessment and Forecast by Material, 2018-2026 14.6.10PIR 14.6.11PCR 14.6.12 Paperboard 14.6.13 Others 15. Company Profiles 15.1. Competition Landscape 15.2. Global Company Share (USD Mn) Overview, 2018 15.3. Company Profiles 15.3.1 SKS Bottle & Packaging, Inc. 15.3.1.1 Corporate Overview 15.3.1.2 Financial Performance 15.3.1.3 Peer Comparison & 3C marketing equation 15.3.1.4 Company Strategy & Channel Management 15.3.2 CHIC CHIQ 15.3.2.1 Corporate Overview 15.3.2.2 Financial Performance 15.3.2.3 Peer Comparison & 3C marketing equation 15.3.2.4 Company Strategy & Channel Management 15.3.3 Elevate Packaging, Inc., 15.3.3.1 Corporate Overview 15.3.3.2 Financial Performance 15.3.3.3 Peer Comparison & 3C marketing equation 15.3.3.4 Company Strategy & Channel Management 15.3.4 Eco Vision Inc., 15.3.4.1 Corporate Overview 15.3.4.2 Financial Performance 15.3.4.3 Peer Comparison & 3C marketing equation 15.3.4.4 Company Strategy & Channel Management 15.3.5 Weltrade Pty Ltd 15.3.5.1 Corporate Overview 15.3.5.2 Financial Performance 15.3.5.3 Peer Comparison & 3C marketing equation 15.3.5.4 Company Strategy & Channel Management 16. Research Sources & Primary Verbatim Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Fri Sep 20 2019 Hits: 14 Rating: 0.00 Votes: 0) Rate It

• Global Experts Meeting on Frontiers in Pediatrics & Neonatology - With a most dynamic approach in the event management, Global Pediatrics 2020 organized by Frontiers Meetings offer a customized platform for each segment of attendees to present their research and experience. This International Conference features some critical attributes to make it worth attending. Attend and meet global Pediatric professionals in the upcoming Global Pediatrics 2020 conference scheduled at Zurich, Switzerland during June 15-17, 2020 (Added: Fri Sep 20 2019 Hits: 11 Rating: 0.00 Votes: 0) Rate It

• International Conference On Advances in Surgery - Surgery 2020 aims to gather leading surgeons, eminent scientists, research scholars, students along with industrial and pharmacy professionals to express their views on the latest technologies for future Surgery research. Surgery is a medical speciality that uses operative manual and instrumental techniques on a patient to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function or appearance or to repair unwanted ruptured areas. Scope & Importance: Surgery 2020 is an international conference composed of multidisciplinary talks about major advances, procedures and clinical studies in transplantation, surgical medicine, cancer, neuroscience, endocrinal, vascular, gastrointestinal, abdominal, head, neck, breast and all other forms of surgery mentioned in scientific sessions. Surgery 2020 will consist of a mixture of brief oral comprising different areas of surgery & Surgical techniques and many other selected topics related to Robotic Surgery, Paediatric Surgery, Obesity and Bariatric Surgery, Plastic & Cosmetic Surgery, Dental Surgery, Transplantation and Artificial Organs Surgery, Surgery and Anaesthesia, Cardiac Surgery, Vein Surgery, Oncology and Surgery with special emphasis on diagnosis, staging and treatment of cancer. Besides, there will be most interesting scientific sessions and workshops and symposium seminars specifically dedicated to relevant fields in surgery, and sessions of proffered papers in Plenary and Keynote presentation (Added: Fri Sep 20 2019 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• Nuclear Medicine Equipment Market: Moving Towards Brighter Future -

  The Global Nuclear Medicine Equipment Market accounted to USD 1.7 billion in 2016 growing at a CAGR of 6.2% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Some of the leading key players profiled in this study: CMR Naviscan, SurgicEye GmbH, Mallinckrodt, Neusoft Corporation, DDD-Diagnostic A/S, CANON MEDICAL SYSTEMS CORPORATION, Mediso Ltd, Digirad Corporation., Siemens, Cardinal Health., GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Bozlu Holding, Compañía Mexicana de Radiología CRG, SA de CV, Neusoft Corporation, TOSHIBA CORPORATION, Bartec Technologies Ltd., Biodex, Cyclopharm

  Get Sample Analysis of This Market Information: @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-nuclear-medicine-equipment-market

  Global Nuclear Medicine Equipment Market - Major Market Drivers and Restraints:

  • Increasing incidences and prevalence of diseases such as cancer
  • Technological advancements in medical imaging devices
  • Government initiatives in modernizing diagnostic imaging centers
  • High cost of nuclear imaging equipment
  • Shorter half-life of radiopharmaceuticals

  Focus of the report

  • CAGR values in the market for the forecast period
  • Key trends in the market place
  • Major players and brands
  • Historical and current market size and projection up to 2026.
  • Detailed overview of parent market
  • Changing market dynamics of the industry

  Avail Discount at @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-nuclear-medicine-equipment-market

  Global Nuclear Medicine Equipment Market - Market Segmentation:

  • By product, the market for nuclear medicine equipment market is segmented into single-photon emission computed tomography (SPECT), planar scintigraphy, hybrid pet. The single-photon emission computed tomography (SPECT) segment is further sub-segmented into standalone, and hybrid.
  • By application, the market for nuclear medicine equipment market is segmented into oncology, cardiology, neurology, and others.
  • On the basis of end-user, the nuclear medicine equipment market is segmented into hospitals, imaging centers, academic & research centers.
  • By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)

  Customization of the Report:

  All segmentation provided above in this report is represented at country level

  All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

  Reasons to Purchase this Report

  • Current and future of Global Nuclear Medicine Equipment Market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

  Access Full Report here@ https://databridgemarketresearch.com/reports/global-nuclear-medicine-equipment-market/

  About Data Bridge Market Research:

  Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

  Contact:

  Data Bridge Market Research

  Tel: +1-888-387-2818

  Email: Sopan.gedam@databridgemarketresearch.com

   

  (Added: Fri Sep 20 2019 Hits: 10 Rating: 0.00 Votes: 0) Rate It

• Supplement Packaging Market Global Trends, Market Share, Industry Size, Growth - Supplement Packaging Market Introduction Global supplement packaging market to value 12 billion by 2026 end and register a CAGR of over 6.2% during forecast period 2019 to 2026. Supplement consumption is necessary for the enhancement of the nutritional value of our daily consumed food. Supplement consumers prioritise information regarding the ingredients and the nutrients that they possess. This information that is important to consumers is communicated to them via packaging and therefore supplement packaging market has been on a rise recently. They also support in strengthening brand position by making the product stand out on retail shelves. Blisters, canisters, bottles, capsules etc. are some of the means of packaging for supplementary products. The decision of which packaging to choose depends on the volume as well as the type of the supplement. Supplement Packaging Market Overview Changing lifestyle patterns and increasing per capita expenditure made dietary supplements as an integral part of daily life. A dietary supplement has gained enormous consumer support in recent times due to the increasing importance of preventive healthcare practices. Increasing demand of dietary supplements among the general population led to the rapid evolution of creative packaging technique to enhance product sales. Manufacturers are mainly focused on creating impulsive buying strategies through packaging led to the robust growth of the market. Further, changing regulatory conditions to increase product stability and integrity led to the robust growth of the market. It is further augmented by expanding the dietary supplement sector due to increasing demand created opportunistic space for manufacturers. North America market is expected to witness a high market share in the global market due to high adoption. It is followed by the European region and it accounts a significant share in the global market. Asia-Pacific regions are expected to witness a high market growth rate during the forecast period due to increasing consumption patterns of dietary supplements. Asia Pacific region is dominated by local manufacturers and expected to remain the same throughout the forecast period. Latin America and Rest of the world market are expected to account a small fraction of market share due to less adoption. Supplement Packaging market players include Alpha Packaging, EPAC HOLDINGS, LLC., Glenroy, Inc., Vitakem Nutraceutical Inc., Assemblies Unlimited, Inc., Makers Nutrition, LLC. and others Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=220&page=requestsample Supplement Packaging Market Segmentation By Product Type + Oblong Bottles + Stress-style Packers + Indented Label Packers + Apothecary Packers + Bags + Pouches + Large Canisters By End User + Pharmaceutical Companies + Nutraceutical Companies By Region + North America + Latin America + Europe + Asia Pacific + Rest of the World Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=220&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global Stent Delivery Systems Market by Material Type, by End-User, and by Region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents Introduction Scope and Objective Assumptions and Acronyms Forecast Factors Research Methodology Executive Summary Industry Cluster Analysis Competition Matrix Strategies Recommendations Market Definition Report Scope (Inclusions & Exclusions) Market Segmentation Global Supplement Packaging Market Overview Global Supplement Packaging Market Revenue (USD Mn) Key Inclusions Porter’s Five Force analysis Market Dynamics Industry Trends Regulatory Guidelines Opportunities in Supplement Packaging Competition Dynamics Company Share Analysis (2018) Top 10 Product Pricing by Region Global Supplement Packaging Market Revenue (USD Mn), 2018-2026 by Product Type Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 Oblong Bottles Stress-style Packers Indented Label Packers Apothecary Packers Bags Pouches Large Canisters Global Supplement Packaging Market Revenue (USD Mn), 2018-2026 by End User Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 Pharmaceutical Companies Nutraceutical Companies Global Supplement Packaging Market Revenue (USD Mn), 2018-2026 by Region Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Region,2026 North America Latin America Europe Asia Pacific Rest of world North America Supplement Packaging Market Revenue (US$ Mn), 2018-2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 US Canada Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 Oblong Bottles Stress-style Packers Indented Label Packers Apothecary Packers Bags Pouches Large Canisters Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 Pharmaceutical Companies Nutraceutical Companies Latin America Supplement Packaging Market Revenue (US$ Mn), 2018-2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 Brazil Mexico Argentina Rest of Latin America Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 Oblong Bottles Stress-style Packers Indented Label Packers Apothecary Packers Bags Pouches Large Canisters Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 Pharmaceutical Companies Nutraceutical Companies Europe America Supplement Packaging Market Revenue (US$ Mn), 2018-2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 Germany France Spain UK Russia Poland Rest of Europe Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 Oblong Bottles Stress-style Packers Indented Label Packers Apothecary Packers Bags Pouches Large Canisters Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 Pharmaceutical Companies Nutraceutical Companies Asia Pacific America Supplement Packaging Market Revenue (US$ Mn), 2018-2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 Emerging Asia China India ASEAN-5 Rest of Emerging Asia Japan Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 Oblong Bottles Stress-style Packers Indented Label Packers Apothecary Packers Bags Pouches Large Canisters Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 Pharmaceutical Companies Nutraceutical Companies Rest of World America Supplement Packaging Market Revenue (US$ Mn), 2018-2026 Key Market Findings Long Term ROI Segments Revenue Opportunity Influencing Factors Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 Middle East South Africa North Africa Rest of World Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026 Oblong Bottles Stress-style Packers Indented Label Packers Apothecary Packers Bags Pouches Large Canisters Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 Pharmaceutical Companies Nutraceutical Companies Company Profiles Competition Landscape Global Company Share (USD Mn) Overview, 2018 Company Profiles Alpha Packaging Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management EPAC HOLDINGS, LLC. Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Glenroy, Inc. Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Vitakem Nutraceutical Inc. Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Assemblies Unlimited, Inc. Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Makers Nutrition, LLC. Corporate Overview Financial Performance Peer Comparison & 3C marketing equation Company Strategy & Channel Management Research Sources & Primary Verbatim Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Thu Sep 19 2019 Hits: 23 Rating: 0.00 Votes: 0) Rate It

• Protein Sequencing Market Global Trends, Market Share, Industry Size, Growth - Global protein sequencing market is estimated to value over USD 1.3 billion by 2026 end and register a CAGR of above 3% during the forecast period 2019-2026. The key factor stimulating the growth of the protein sequencing market is the increased funding for proteomics research and growing focus towards the development of the target-based drug. Advancements in analytical methods and peptide-sequencing methods have represented a lucrative opportunity for manufacturers. Technological advancements in mass spectrometer are complementing the market growth. The increasing demand for protein biomarkers in the drug development process is also playing a vital role in the expansion of the market. The market is bifurcated into product & service, technology, application, end-user, and region. In terms of product & service, protein sequencing services are expected to be the front runner of the market. The rise in the advancement of instruments has led to more launch and availability of advanced instruments which played a vital role in the escalation of the market. Furthermore, the high cost of sequencing infrastructure and fewer complexities associated with the procedure of protein sequencing is bolstering the market. Mass spectrometry technology is expected to witness high growth owing to its benefits such as identification of modified proteins and cost-efficiency. Prominent players aiming towards the launch of technologically advanced spectrometry instruments are propelling the market growth. Academic institutes and research centers segment are expected to control the market growth. Rising research and development activities coupled with an increased funding from private and public institutes regarding proteomic research is escalating the growth of academic institutes and research, thus propelling the market. North America is the global leader of the market. Increase in research and development activities alongside increased funding from government and private organizations towards proteomic research is boosting the presence of the market in the region. Furthermore, a rise in drug development activities and increasing focus towards structure-based drug design are stimulating the market in regions like the US and Canada. The presence of prominent players in the region is also positively influencing the market. Major players of the market are SGS S.A, Thermo Fisher Scientific, Shimadzu, Agilent Technologies, Selvita, Charles River Laboratories, Waters Corporation, and Rapid Novor. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3383&page=requestsample Competitive Landscape: · Thermo Fisher Scientific is one of the biggest players in the market and through product innovation and technological innovation bolstered the market. The company launched mass spectrometry platforms like Orbitrap, Fusion Lumos Tribrid Mass Spectrum. The product launches helped the company's growth in consumables as well · Shimadzu in 2018, launched Quadrupole time-of-flight (Q-TOF) LCMS-9030 System · SGS S.A acquired Vanguard Sciences Inc in 2018. The acquisition helped SGS S.A to enhance its protein sequencing offering for the safety of food Global Protein Sequencing Market Segmentation By Product & Service ● Sample Preparation Products & Services ● Protein Sequencing Products ▪ Reagents & Consumables ▪ Instruments ▪ Analysis Products/Software ● Protein Sequencing Services By Technology ● Edman Degradation ● Mass Spectrometry By Application ● Biotherapeutics ● Genetic Engineering ● Other Applications By End User ● Academic Institutes & Research Centers ● Pharmaceutical & Biotechnology Companies ● Other End Users By Region ● North America ● Europe ● Asia Pacific ● Latin America ● Rest of the World Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3383&page=askfordiscount FutureWise Key Takeaways ● Growth Prospects ● SWOT Analysis ● Key Trends ● Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global protein sequencing market by product & service, by technology, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • Evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies Table of Contents 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2 Research Methodology 2.1 Research Data 2.1.1 Secondary Research 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Research 2.1.2.1 Key Data From Primary Sources 2.1.2.1.1 Breakdown of Primary Interviews 2.2 Market Size Estimation 2.2.1 Revenue-Based Market Estimation 2.2.2 End-User-Based Market Estimation 2.2.3 Primary Research Validation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3 Executive Summary 4 Premium Insights 4.1 Protein Sequencing Market Overview 4.2 Protein Sequencing Market, By Product & Service (2018 vs 2026) 4.3 Protein Sequencing Market, By Technology, 2018 vs 2026 4.4 Protein Sequencing Market, By Application, 2018 vs 2026 4.5 Protein Sequencing Market, By End User, 2018 vs 2026 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Increasing Focus on Target-Based Drug Development By Pharmaceutical and Biotechnology Companies 5.2.1.2 Advancements in Clinical Mass Spectrometry and Analytical Techniques 5.2.1.3 Increasing Public-Private Financial Support for Proteomic Research 5.2.2 Restraints 5.2.2.1 High Infrastructure Costs 5.2.3 Opportunities 5.2.3.1 Technological Advancements for the Identification of Isobaric Residues in Protein Sequences 5.2.4 Challenges 5.2.4.1 Preparation of Pure Protein Samples 5.2.4.2 Need for Skilled Researchers and Laboratory Professionals 6 Protein Sequencing Market, By Product & Service 6.1 Introduction 6.2 Sample Preparation Products & Services 6.2.1 Growing Need for Standardized Sample Preparation Solutions is A Major Driver for the Sample Preparation Products & Services Market 6.3 Protein Sequencing Products 6.3.1 Reagents & Consumables 6.3.1.1 Growing Number of Sequencing Procedures to Drive the Demand for Protein Sequencing Reagents & Consumables 6.3.2 Instruments 6.3.2.1 Mass Spectrometry Instruments 6.3.2.1.1 Technological Advancements to Drive the Adoption of Mass Spectrometry Instruments 6.3.2.2 Edman Degradation Sequencers 6.3.2.2.1 High Accuracy of Edman Degradation Method to Drive the Adoption of These Products 6.3.3 Analysis Products/Software 6.3.3.1 Protein Sequencing Analysis Products/Software to Witness the Highest Growth Rate During the Forecast Period 6.4 Protein Sequencing Services 6.4.1 Protein Sequencing Services to Register the Highest Growth Between 2018 & 2026 7 Protein Sequencing Market, By Technology 7.1 Introduction 7.2 Mass Spectrometry 7.2.1 High-Throughput Sequencing Capabilities and Cost Efficiency to Drive the Adoption of Mass Spectrometry Protein Sequencing 7.3 Edman Degradation 7.3.1 High Accuracy of the Edman Degradation Method is the Key Factor Driving Its Adoption in the Market 8 Protein Sequencing Market, By Application 8.1 Introduction 8.2 Biotherapeutics 8.2.1 Biotherapeutics Segment to Witness the Highest Growth During the Forecast Period 8.3 Genetic Engineering 8.3.1 Large Number of Research Projects Focused on Genetically Modified Organisms & Technological Advancements—Key Factors Driving Market Growth 8.4 Other Applications 9 Protein Sequencing Market, By End User 9.1 Introduction 9.2 Academic Institutes & Research Centers 9.2.1 Academic Institutes & Research Centers to Account for the Largest Share of the Market Owing to the Increasing Funding for Proteomics Research 9.3 Pharmaceutical & Biotechnology Companies 9.3.1 Increasing R&D Expenditure of Major Pharmaceutical and Biotechnology Companies to Drive Market Growth 9.4 Other End Users 10 Protein Sequencing Market, By Region 10.1 Introduction 10.2 North America 10.2.1 US 10.2.1.1 Launch of Advanced Protein Sequencing Products & the Strong Presence of Leading Players are Driving the Growth of the Protein Sequencing Market in the Us 10.2.2 Canada 10.2.2.1 Financial Support From Government and Private Organizations for R&D in the Proteomics Field—Major Factor Supporting Market Growth 10.3 Europe 10.3.1 Germany 10.3.1.1 Favorable Funding Scenario for Life Science Research to Drive the Growth of the Protein Sequencing Market in Germany 10.3.2 France 10.3.2.1 Rising Demand for Biotherapeutics and Biotechnology in the Country to Drive the Adoption of Protein Sequencing 10.3.3 UK 10.3.3.1 Presence of A Large Life Sciences Industry and the Continued Growth of the Biopharmaceuticals Sector are the Major Factors Driving Market Growth 10.3.4 Rest of Europe 10.4 Asia Pacific 10.4.1 China 10.4.1.1 China to Register the Highest Growth in the Asia Pacific Protein Sequencing Market During the Forecast Period 10.4.2 Japan 10.4.2.1 Strong Life Sciences R&D Infrastructure and A Favorable Government Funding Scenario are Key Factors Driving Market Growth 10.4.3 India 10.4.3.1 Implementation of Favorable Government Initiatives to Support Life Sciences Research to Support the Growth of the Protein Sequencing Market in India 10.4.4 Rest of Asia Pacific 10.5 Rest of the World 11 Competitive Landscape 11.1 Overview 11.2 Market Share Analysis 11.3 Competitive Situation and Trends 11.3.1 Product Launches and Services 11.3.2 Partnerships 11.3.3 Acquisitions 11.3.4 Expansions 12 Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise Perspective)* 12.1 Agilent Technologies, Inc. 12.2 Bioinformatics Solutions 12.3 Charles River Laboratories 12.4 Proteome Factory 12.5 Rapid Novor Inc. 12.6 Selvita 12.7 SGS 12.8 Shimadzu Corporation 12.9 Thermo Fisher Scientific Inc. 12.10 Waters 13. Research Finding and Conclusion 14. Appendix 15.1 Research Methodology 15 .2 Research Data Source Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Thu Sep 19 2019 Hits: 15 Rating: 0.00 Votes: 0) Rate It

• Oligonucleotide Synthesis Market Global Trends, Market Share, Industry Size, Growth - The oligonucleotide synthesis market is anticipated to value over USD 4 billion by 2026 with a CAGR of over 12% during the forecast period 2019 to 2026. Oligonucleotide synthesis is the process of compounding relatively short fragments of nucleic acid with a defined sequence. It is a vital part of genetic research and has a wide range of applications like diagnosis, tissue engineering, library preparation, DNA sequencing, PCR assays and so on. Due to such scope in the research and development, the oligonucleotide market is growing rapidly. The inclination towards finding more efficient alternatives to traditional diagnostics and treatments is one of the factors driving the scale-up of the oligonucleotide synthesis market. For the past few years, several genetic diagnostic and clinical measures have boosted the market of oligonucleotide synthesis. The oligonucleotide synthesizing equipment are expected to hold a large market share as they are the primary preference of end users. The key market players provide a range of synthesizers that add value to the market. Oligonucleotide synthesis is impossible without suitable reagents like linkers, activators, dyes, DNA probes and so on. This is a driving factor for the rise in demand of reagents in the market and is anticipated to hold a large share in the market. Based on the applications, PCR primers and fluorescence in situ hybridization are anticipated to dominate the oligonucleotide synthesis market due to its wide use across the globe. Currently, the pharmaceutical and biotechnological companies have their focus on the genetic sector for effective therapeutics and diagnostics. The investments by these companies in genetic research are growth factors for the oligonucleotide market. North America region has its main focus on genetic research and development, it also possesses advanced technology as well as regulatory support for the study of genetic advancements. This factor dominates North America in the oligonucleotide synthesis market. Moreover, the Asia Pacific region has a good scope in the market due to inclination towards adopting genetic research. The key market players are Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare Dharmacon Inc., Agilent Technologies and so on. Thermo Fisher Scientific has a range of advanced genetic equipment with several applications like DNA sequencing, PCR, protein biology, etc. which are anticipated to be drivers for the market growth. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3379&page=requestsample FutureWise Key Takeaways: ● Investment in genetic research ● Focus on advanced genetic synthesizers ● Collaborations with genetic research organizations Global Oligonucleotide Synthesis Market Segmentation: By Product: ● Oligonucleotides ● Equipment/ synthesizers ● Reagents ● Services By Application: ● PCR primers ● PCR assays-panels ● Sequencing ● DNA microarrays ● Fluorescence in situ hybridization ● Antisense oligonucleotides ● Other applications By End User: ● Pharmaceutical-biotechnology companies ● Diagnostic laboratories ● Academic research institutes By Region ● North America ● Europe ● Asia Pacific ● Latin America ● Middle East & Africa Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3379&page=askfordiscount Competitive Landscape: ● Tier 1 players- established companies in the market with a major market share ● Tier 2 players ● Emerging players which are growing rapidly ● New Entrants Objectives of the Study: ● To provide with an exhaustive analysis on the oligonucleotide synthesis market by product, by application, by end user and by region ● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ● To evaluate and forecast micro-markets and the overall market ● To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa ● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions ● Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents Table of Contents Chapter 1 Executive Summary 1.1 Market Snapshot Chapter 2 Research Methodology 2.1 Information procurement 2.1.1 Purchased database: 2.1.2 FutureWise's Internal Database 2.2 Information or Data Analysis 2.3 Market Formulation - Validation 2.4 Approaches for Market Estimation 2.4.1 Approach 1: Commodity flow - bottom up approach 2.4.2 Approach 2: Top down and parent market analysis Chapter 3 Oligonucleotide Synthesis Market Variables, Trends - Scope 3.1 Market Segmentation - Scope 3.1.1 Market driver analysis 3.1.1.1 Strong pipeline of oligonucleotide therapeutics in clinical trials 3.1.1.2 Changing regulatory environments for genetic research and its applications in healthcare 3.1.1.3 High R - D spending of pharmaceutical - biotechnology companies 3.1.1.4 Increased public - private spending on genomics 3.1.1.5 Technological advancements in gene editing technologies 3.1.1.6 Exponentially declining cost of sequencing 3.1.1.7 Rising demand for synthetic genes 3.1.2 Market restraint analysis 3.1.2.1 Need for advanced oligo synthesis solutions 3.1.2.2 High cost associated with genomics research 3.1.2.3 Increasing wages of skilled employees in life science sector 3.1.2.4 Lack of skilled professionals and research support in undeveloped countries 3.2 Penetration - Growth Prospect Mapping for Application, 3.3 Oligonucleotide Synthesis -SWOT Analysis, By Factor (Political - Legal, Economic And Technological) 3.4 Industry Analysis - Porter’s Chapter 4 Oligonucleotide Synthesis Market Categorization: Product Estimates - Trend Analysis 4.1 Global Oligonucleotide Synthesis Market: Product Movement Analysis, 2017 - 2025 4.2 Oligonucleotides 4.2.1 Global oligonucleotides market, 2014 - 2026 (USD Million) 4.2.2 Oligonucleotides, by product type 4.2.2.1 Column-based oligos 4.2.2.1.1 Global column-based oligos market, 2014 - 2026 (USD Million) 4.2.2.2 Array-based oligos 4.2.2.2.1 Global array-based oligos market, 2014 - 2026 (USD Million) 4.2.3 Oligonucleotides, by nucleic acid type 4.2.3.1 DNA oligos 4.2.3.1.1 Global DNA oligo market, 2014 - 2026 (USD Million) 4.2.3.2 RNA oligos 4.2.3.2.1 Global RNA oligo market, 2014 - 2026 (USD Million) 4.3 Equipment/ Synthesizers 4.3.1 Global oligonucleotide synthesis equipment market, 2014 - 2026 (USD Million) 4.4 Reagents 4.4.1 Global oligonucleotide synthesis reagents market, 2014 - 2026 (USD Million) 4.5 Services 4.5.1 Global oligonucleotide services market, 2014 - 2026 (USD Million) 4.5.2 Oligo synthesis 4.5.2.1 Global oligo synthesis services market, 2014 - 2026 (USD Million) 4.5.2.2 25 nmol 4.5.2.2.1 Global 25 nmol oligo synthesis services market, 2014 - 2026 (USD Million) 4.5.2.3 50 nmol 4.5.2.3.1 Global 50 nmol oligo synthesis services market, 2014 - 2026 (USD Million) 4.5.2.4 200 nmol 4.5.2.4.1 Global 200 nmol oligo synthesis services market, 2014 - 2026 (USD Million) 4.5.2.5 1,000 nmol 4.5.2.5.1 Global 1,000 nmol oligo synthesis services market, 2014 - 2026 (USD Million) 4.5.2.6 10,000 nmol 4.5.2.6.1 Global 10,000 nmol oligo synthesis services market, 2014 - 2026 (USD Million) 4.5.3 Purification 4.5.3.1 Global oligonucleotide purification services market, 2014 - 2026 (USD Million) 4.5.4 Modification 4.5.4.1 Global oligonucleotide modification services market, 2014 - 2026 (USD Million) Chapter 5 Oligonucleotide Synthesis Market Categorization: Application Estimates - Trend Analysis 5.1 Global Oligonucleotide Synthesis Market: Application Movement Analysis, 2017 - 2025 5.2 PCR primers 5.2.1 Global PCR primer-based oligo synthesis market, 2014 - 2026 (USD Million) 5.3 PCR Assays - Panels 5.3.1 Global PCR assays - panels-based oligo synthesis market, 2014 - 2026 (USD Million) 5.4 Sequencing 5.4.1 Global sequencing-based oligo synthesis market, 2014 - 2026 (USD Million) 5.5 DNA Microarrays 5.5.1 Global DNA microarray-based oligonucleotide synthesis market, 2014 - 2026 (USD Million) 5.6 Fluorescence In Situ Hybridization (FISH) 5.6.1 Global FISH-based oligonucleotide synthesis market, 2014 - 2026 (USD Million) 5.7 Antisense Oligonucleotides 5.7.1 Global antisense oligonucleotide-based oligo synthesis market, 2014 - 2026 (USD Million) 5.8 Other Applications 5.8.1 Global other oligo synthesis applications market, 2014 - 2026 (USD Million) Chapter 6 Oligonucleotide Synthesis Market Categorization: End Use Estimates - Trend Analysis 6.1 Global Oligonucleotide Synthesis Market: End Use Movement Analysis, 2017 - 2025 6.2 Pharmaceutical - Biotechnology Companies 6.2.1 Global pharmaceutical - biotechnology companies-based oligo synthesis market, 2014 - 2026 (USD Million) 6.3 Diagnostic Laboratories 6.3.1 Global diagnostic laboratories-based oligo synthesis market, 2014 - 2026 (USD Million) 6.4 Academic Research Institutes 6.4.1 Global academic research institutes-based oligo synthesis market, 2014 - 2026 (USD Million) Chapter 7 Oligonucleotide Synthesis Market Categorization: Regional Estimates - Trend Analysis, by Product, Applications, - End Use 7.1 Oligonucleotide Synthesis Market Share By Region, 2016 - 2026 7.2 North America 7.2.1 North America oligonucleotide synthesis market, 2014 - 2026 (USD Million) 7.2.2 U.S. 7.2.2.1 U.S. oligonucleotide synthesis market, by product 2014 - 2026 (USD Million) 7.2.2.2 U.S. oligonucleotide synthesis market, by application 2014 - 2026 (USD Million) 7.2.2.3 U.S. oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million) 7.2.3 Canada 7.2.3.1 Canada oligonucleotide synthesis market, by product 2014 - 2026 (USD Million) 7.2.3.2 Canada oligonucleotide synthesis market, by application 2014 - 2026 (USD Million) 7.2.3.3 Canada oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million) 7.3 Europe 7.3.1 Europe oligonucleotide synthesis market, 2014 - 2026 (USD Million) 7.3.2 Germany 7.3.2.1 Germany oligonucleotide synthesis market, by product 2014 - 2026 (USD Million) 7.3.2.2 Germany oligonucleotide synthesis market, by application 2014 - 2026 (USD Million) 7.3.2.3 Germany oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million) 7.3.3 U.K. 7.3.3.1 U.K. oligonucleotide synthesis market, by product 2014 - 2026 (USD Million) 7.3.3.2 U.K. oligonucleotide synthesis market, by application 2014 - 2026 (USD Million) 7.3.3.3 U.K. oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million) 7.4 Asia Pacific 7.4.1 Asia Pacific oligonucleotide synthesis market, 2014 - 2026 (USD Million) 7.4.2 Japan 7.4.2.1 Japan oligonucleotide synthesis market, by product 2014 - 2026 (USD Million) 7.4.2.2 Japan oligonucleotide synthesis market, by application 2014 - 2026 (USD Million) 7.4.2.3 Japan oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million) 7.4.3 China 7.4.3.1 China oligonucleotide synthesis market, by product 2014 - 2026 (USD Million) 7.4.3.2 China oligonucleotide synthesis market, by application 2014 - 2026 (USD Million) 7.4.3.3 China oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million) 7.5 Latin America 7.5.1 Latin America oligonucleotide synthesis market, 2014 - 2026 (USD Million) 7.5.2 Brazil 7.5.2.1 Brazil oligonucleotide synthesis market, by product 2014 - 2026 (USD Million) 7.5.2.2 Brazil oligonucleotide synthesis market, by application 2014 - 2026 (USD Million) 7.5.2.3 Brazil oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million) 7.6 Middle East - Africa (MEA) 7.6.1 Middle East - Africa oligonucleotide synthesis market, 2014 - 2026 (USD Million) 7.6.2 South Africa 7.6.2.1 South Africa oligonucleotide synthesis market, by product 2014 - 2026 (USD Million) 7.6.2.2 South Africa oligonucleotide synthesis market, by application 2014 - 2026 (USD Million) 7.6.2.3 South Africa oligonucleotide synthesis market, by end use 2014 - 2026 (USD Million) Chapter 8 Competitive Landscape 8.1 Strategy Framework 8.2 Market Participation Categorization 8.3 List of Companies 8.4 Company Profiles 8.4.1 Thermo Fisher Scientific, Inc. 8.4.1.1 Company overview 8.4.1.1.1 Life Technologies Corporation 8.4.1.2 Financial performance 8.4.1.3 Product benchmarking 8.4.1.4 Strategic initiatives 8.4.2 Merck KGaA 8.4.2.1 Company overview 8.4.2.1.1 Sigma-Aldrich Co. LLC 8.4.2.1.2 Merck Millipore 8.4.2.2 Financial performance 8.4.2.2.1 Financial performance 8.4.2.3 Product Benchmarking 8.4.2.4 Strategic initiatives 8.4.3 GE Healthcare Dharmacon Inc. 8.4.3.1 Company overview 8.4.3.2 Financial performance 8.4.3.3 Product Benchmarking 8.4.3.4 Strategic Initiatives 8.4.4 Agilent Technologies 8.4.4.1 Company overview 8.4.4.2 Financial performance 8.4.4.3 Product Benchmarking 8.4.4.4 Strategic initiatives 8.4.5 Bio-synthesis 8.4.5.1 Company overview 8.4.5.2 Financial performance 8.4.5.3 Product benchmarking 8.4.5.4 Strategic initiatives 8.4.6 Kaneka Eurogentec S.A. 8.4.6.1 Company overview 8.4.6.2 Financial performance 8.4.6.3 Product benchmarking 8.4.6.4 Strategic initiatives 8.4.7 Integrated DNA Technologies, Inc. 8.4.7.1 Company overview 8.4.7.2 Financial performance 8.4.7.3 Product benchmarking 8.4.7.4 Strategic initiative 8.4.8 BioAutomation 8.4.8.1 Company overview 8.4.8.2 Financial performance 8.4.8.3 Product benchmarking 8.4.8.4 Strategic initiatives 8.4.9 LGC Biosearch Technologies 8.4.9.1 Company overview 8.4.9.2 Financial performance 8.4.9.3 Product benchmarking 8.4.9.4 Strategic initiatives 8.4.10 Biolegio B.V. 8.4.10.1 Company overview 8.4.10.2 Financial performance 8.4.10.3 Product benchmarking 8.4.10.4 Strategic initiatives 9 Research Finding and Conclusion 10 Appendix 10.1 Research Methodology 10.2 Research Data Source Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Thu Sep 19 2019 Hits: 22 Rating: 0.00 Votes: 0) Rate It

• Medical Biometrics Market Global Trends, Market Share, Industry Size, Growth - The global medical biometrics market is estimated to value over USD 7 Billion by 2029 end and register a CAGR of over 23% from 2019 to 2029. The factors driving the growth of the market the increasing prevalence of cyber-attacks and the growing healthcare IT application. Multiple initiatives taken by the government in order to impede healthcare fraud and improve the security of healthcare information is stimulating in the market. Rising healthcare infrastructure is developing nations is fueling the growth of the market as well. The quickness provided by these biometrics had a positive influence on the market. For example, Genkey Solutions B.V based, a Dutch company deployed medical claim system in Ghana in 2014. The deployment of the system enabled approximately four million users to go cashless treatment. The rising scope of contactless biometrics is also positively influencing the market. The market is bifurcated into by type, technology, end-user, geography. Based on type the market consists of contact biometric and non-contact biometric. Based on technology, the market consists of single-factor authentication and multi-factor authentication. Single-factor is expected to dominate the growth of the market. Single-factor authentication is cost-effective and easy to install. Rising deployment of iris recognition, face recognition, voice recognition in government sectors and BFSI is driving the demand of single-factor authentication, thus propelling the market. Iris and vein recognition are secured biometric technology owing to uniqueness of identity. The combination of iris and facial recognition is expected to create a progressing trend. Such biometric technology eliminates the stigma linked with fingerprint technology. Based on end-user, healthcare institutes are expected to witness significant growth. The rising incidence of data theft, secured medical records, secured patient privacy and cyber-attacks on healthcare institutes and hospitals have prompted for the adoption of the biometric solution. In terms of region, North America is expected to dictate the growth of the market. Presence of prominent players like Cross Match Technologies and Aware is driving the market in the region. In addition, favorable governments policies in the US and Canada is boosting the presence of the market in the region. Asia-Pacific region is expected to be a lucrative region for the manufacturers. Rising healthcare infrastructure and government support are elevating the market in the region. The Indian government launched a healthcare program called National Health Assurance Mission in India, a database facility which caters the citizens of the country with healthcare services at affordable prices. Prominent players of the market are Integrated Biometrics, Fujitsu, 3M, Imprivata, Inc., BIO-key International, Agbitio, Qualcomm Technologies, Inc, NEC Corporation, Fujitsu, MorphoTrust, Suprema, Hitachi Ltd., Genkey Solutions B.V. and Nuance Communications, Inc., Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=2299&page=requestsample Global Medical Biometrics Market Segmentation By Type Contact biometric Non-contact biometric By Technology Single-factor authentication Iris Recognition Face Recognition Signature Recognition Hand Recognition Voice Recognition Fingerprint Recognition Others Multi-factor authentication Biometric Card Password Others By End-User Hospitals Clinics Healthcare Institutes Research Laboratories By Region: North America Latin America Europe Asia-Pacific Rest of the World Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=2299&page=askfordiscount Competitive Landscape: ● Tier 1 players- established companies in the market with a major market share ● Tier 2 players ● Emerging players which are growing rapidly ● New Entrants Futurewise Key Takeaways ● Growth Prospects ● SWOT Analysis ● Key Trends ● Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global medical biometrics market by type, by technology, by end-users, and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Thu Sep 19 2019 Hits: 16 Rating: 0.00 Votes: 0) Rate It

• Immunoprecipitation Market Global Trends, Market Share, Industry Size, Growth - Global Immunoprecipitation Market to value over USD 720 Million and register a CAGR of over 4% during the forecast period 2019 to 2026. The immunoprecipitation market is witnessing significant growth due to a rise in research activities undertaken in the medical and life sciences industry. The research is usually sponsored and receives federal support which is also regarded as a substantial factor adding to the market’s growth during the forecast period. In order to identify antigens associated with autoimmune diseases, the market plays a key role and thus is profoundly demanded. The factors for early diagnosis of antigens, accuracy and speed are driving market growth. Based on type, the immunoprecipitation market is segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation and RNA immunoprecipitation. Individual immunoprecipitation is projected to be the fastest-growing sector during the forecasted time frame and register a healthy CAGR. The wide application spectrum offered by individual immunoprecipitation is a principal factor aiding its growth and highly precise diagnosis capability also aid in the expansion of the immunoprecipitation market size. By product type, the market is segmented into kits, reagents and accessories. The kits segment is expected to grow at a healthy CAGR due to their employment in various processes. Heavy demand due to universal operability encourages the growth of this segment. Based on the region, The Asia Pacific is predicted to grow at the highest CAGR during the forecast period. Federal support and increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period. North America is predicted to garner major market share due to the presence of global players and developed medical practices. Prominent players are Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, GenScript., and BioLegend and Cell Signaling Technology. Competitive Landscape ● Thermo Fisher Scientific opened its new bioprocess design centre in Shanghai to connect and collaborate with biologic developers to design optimal bioprocessing solutions ● Abcam entered into an agreement with Roche, a leading biotech company, under which Abcam obtained the exclusive rights to the product portfolio of Spring, which consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3381&page=requestsample Global Immunoprecipitation Market Segmentation By Type ● Individual Immunoprecipitation ● Co-Immunoprecipitation ● Chromatin Immunoprecipitation ● RNA Immunoprecipitation By Product ● Kits ● Reagents ■ Antibodies ➢ By Type ○ Primary Antibodies ○ Secondary Antibodies ■ Beads ➢ By Type ○ Agarose Beads ○ Magnetic Beads ○ Buffers ● Accessories By End User ● Academic & Research Institutes ● Pharmaceutical & Biotechnology Companies ● Contract Research Organizations By Region ● North America ● Europe ● Asia Pacific ● Latin America ● Middle East & Africa Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3381&page=askfordiscount Objectives of the Study: ● To provide with an exhaustive analysis on the global immunoprecipitation market by type, by product, by end-user, and by region ● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ● To evaluate and forecast micro-markets and the overall market ● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa ● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions ● Profiling of companies to evaluate their market shares, strategies, financial and core competencies Table of Contents 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Stakeholders 1.6 Limitations 2 Research Methodology 2.1 Research Approach 2.1.1 Secondary Research 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Research 2.1.2.1 Key Data From Primary Sources 2.1.2.2 Break Down of Primaries 2.1.2.3 Key Industry Insights 2.2 Market Size Estimation 2.3 Data Triangulation Approach 2.4 Assumptions for the Study 3 Executive Summary 4 Premium Insights 4.1 Immunoprecipitation: Market Overview 4.2 Immunoprecipitation Market, By Product (2018–2026) 4.3 North America: Immunoprecipitation Market, By Type (2018) 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Market Drivers 5.2.1.1 Increasing Number of Life Sciences Research Activities 5.2.1.2 Growing Need to Identify Antigens That are Associated With Autoimmune Diseases 5.2.2 Restraints 5.2.2.1 Presence of Alternative Technologies 5.2.3 Opportunities 5.2.3.1 Increasing Focus on Biomarker Discovery 5.2.4 Challenges 5.2.4.1 Quality Concerns Over Research Antibodies 6 Immunoprecipitation Market, By Type 6.1 Introduction 6.2 Individual Immunoprecipitation 6.2.1 Increasing Demand for Biologics is Driving the Growth of the Market 6.3 Co-Immunoprecipitation 6.3.1 Increasing Use of Co-Ip to Study Protein Complexes Forms A Key Market Driver 6.4 Chromatin Immunoprecipitation 6.4.1 Growing Adoption of High-Throughput Technologies Will Contribute to Adoption of Chip 6.5 Rna Immunoprecipitation 6.5.1 Availability of Government Funding Will Drive the Adoption of Rip Kits 7 Immunoprecipitation Market, By Product 7.1 Introduction 7.2 Kits 7.2.1 Kits Segment to Account for the Largest Share of the Immunoprecipitation Market During the Forecast Period 7.3 Reagents 7.3.1 Antibodies 7.3.1.1 Antibodies, By Type 7.3.1.1.1 Primary Antibodies 7.3.1.1.1.1 Primary Antibodies to Account for the Largest Share of the Immunoprecipitation Antibodies Market During the Forecast Period 7.3.1.1.2 Secondary Antibodies 7.3.1.1.2.1 Low Cost of Production - A Major Factor Driving the Growth of the Secondary Antibodies Market 7.3.2 Beads 7.3.2.1 Beads, By Type 7.3.2.2 Agarose Beads 7.3.2.2.1 High Binding Capacity and Lower Cost – Factors Supporting the Wide Use of Agarose Beads in Research Laboratories 7.3.2.3 Magnetic Beads 7.3.2.3.1 Magnetic Bead-Based Separation Helps Increase Throughput and Reduces Hands-On Time 7.3.2.4 Buffers 7.3.2.4.1 Buffer Solutions Play an Important Role in Maintaining Ph Balance in Ip Assays 7.4 Accessories 8 Immunoprecipitation Market, By End User 8.1 Introduction 8.2 Academic & Research Institutes 8.2.1 Academic & Research Institutes are the Largest End Users of Immunoprecipitation 8.3 Pharmaceutical & Biotechnology Companies 8.3.1 Increasing Demand for Protein-Based Drugs to Drive the Demand for Immunoprecipitation in This End-User Segment 8.4 Contract Research Organizations 8.4.1 Growth in Outsourcing of Protein Purification Activities - A Major Factor Driving the Demand for Immunoprecipitation Technologies in Contract Research Organizations 9 Immunoprecipitation Market, By Region 9.1 Introduction 9.2 North America 9.2.1 Us 9.2.1.1 Growing Research Will Drive Market Growth 9.2.2 Canada 9.2.2.1 Increasing Genomics and Proteomics Research to Drive the Adoption of Immunoprecipitation in the Coming Years 9.3 Europe 9.3.1 Growth of the Life Sciences Sector Will Support the Demand for Immunoprecipitation 9.4 Asia Pacific 9.4.1 Increasing Demand for Novel Antibody and Protein-Based Drugs Support Market Growth in the Asia Pacific 9.5 Rest of the World 10 Competitive Landscape 10.1 Overview 10.2 Vendor Benchmarking 10.3 Competitive Leadership Mapping 10.3.1 Visionary Leaders 10.3.2 Innovators 10.3.3 Dynamic Differentiators 10.3.4 Emerging Companies 10.4 Market Ranking Analysis, 2018 10.5 Competitive Situation and Trends 10.5.1 Expansions 10.5.2 Collaborations, Partnerships, and Agreements 10.5.3 Product Launches 10.5.4 Acquisitions 11 Company Profiles (Business Overview, Products Offered, Recent Developments, FutureWise Perspective)* 11.1 Thermo Fisher Scientific 11.2 Abcam 11.3 Genscript 11.4 Merck KGaA 11.5 Bio-Rad Laboratories 11.6 Biolegend 11.7 Takara Bio 11.8 Rockland Immunochemicals 11.9 Cell Signaling Technology 11.10 Geno Technology 12. Assumptions and Acronyms 13. Research Methodology 14. List of Sources of Information (Primary and Secondary) Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Thu Sep 19 2019 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• Immune Repertoire Sequencing Market Global Trends, Market Share, Industry Size, Growth - Immune repertoire sequencing market is forecasted to value over US$ 175 Million by 2029 end and a register a CAGR of over 7.5% from 2019 to 2029. Immune repertoire sequencing is vastly utilized in biomarker discovery. It's used to improve the cost-effectiveness and success rate of rational drug development. Immune repertoire sequencing is significant in understanding the human body’s auto-defense technique against outer agents. Increasing research and development have been stimulating the growth of the market. According to the latest research, Immune repertoire sequencing can be used to detect systemic sclerosis-related pulmonary hypertension (SSc-PAH). Hence, increasing research is fueling the growth of the market. Rising prevalence of cancer and other infectious diseases is also boosting the growth of the market. Prominent players launching innovative products are also boosting the growth of the market. The innovation of products has led to extensive use of clinical requirements for patients which fueled the growth of the market. The immune repertoire sequencing market is segmented by component, by application, and by the end user. By component, the market is bifurcated into assay kits and software & services. The assay kits are further divided into TCR Kits and BCR Kits. Assay kit is expected to hold a major share of the market in the forecast period. TCR Kits control the adaptive immune system's capability to create a vast collection of T-cell receptors. Multiple companies are looking for merging in order to develop repertoire sequencing kits for immunotherapy response of a specific kind. For example, MIODx and DiaCarta collaborated together to develop MIODX's ClonoMapto predict the response of the patient to immunotherapy. Such kits will help in providing an accurate understanding of response and behavior of adaptive immunity. On the basis of software & services, the market is bifurcated into analytical software, sequencing services, and data analysis services. The end users of the market are infectious diseases, vaccine development, cancer immunotherapy, autoimmune disease, and transplant rejection & tolerance. Rising infectious diseases and research regarding cancer immunotherapy is expected to drive the growth of the market. The challenges regarding distinguishing biological variations from errors are expected to hinder the growth of the market. Limitation in providing accurate data has resulted in unsatisfactory performance from bioinformatics techniques like high throughput screening which has put further restrains regarding the growth of the market. In terms of region, North America is expected to hold a vast share of the market. Rising demand for immunotherapy for other infectious diseases and cancer is the key reason behind the growth of the market in the region. According to the U.S National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer are expected to be diagnosed in the U.S. Immune repertoire sequencing plays a vital role in fighting cancer and other infectious diseases. Europe is expected to achieve the highest growth in the forecast period. The increased funding by the government alongside rising healthcare expenditure is expected to expand the size of the market in the region. Asia-Pacific region is also predicted to show immense growth of the market in the coming years. Rising adoption of immune repertoire sequencing in developing nations is expected to spur the size of the market. Latest developments by developing countries like Japan for the integration of advanced technology are expected to stimulate the size of the market. Prominent players of the market are CD Genomics, Atreca Inc., ArcherDX, Illumina Inc., Roche Holding AG, Adaptive Biotechnologies and ThermoFisher Scientific Inc. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=256&page=requestsample Immune Repertoire Sequencing Market Segmentation: By Component Assay Kits • TCR Kits • BCR Kits Software & Services • Analytical Software • Sequencing Services • Data Analysis Services By Application • Biomaker Discovery • Infectious Diseases • Vaccine development and efficacy • Cancer Immunotherapy • Autoimmune Disease • Transplant rejection and Tolerance • Others By Region: • Europe • North America • APAC • Latin America • Rest of World Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=256&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the immune repertoire sequencing market based on the components, end users and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1. Market Introduction • Market Definition • Market Taxonomy 2. Executive Summary • Market Overview • Market Analysis 3. Historical Market Value (US$ Mn) and By Component, 2014-2018 Assay Kits • TCR Kits • BCR Kits Software & Services • Analytical Software • Sequencing Services • Data Analysis Services Market Value (US$ Mn) and Forecast By Component, 2018-2029 4. Historical Market Value(US$ Mn) By Application, 2014-2018 • Biomarker Discovery • Infectious Diseases • Vaccine Development and efficacy • Cancer Immunotherapy • Autoimmune Disease • Transplant Rejection and Tolerance • Others • Market Value (US$ Mn) Forecast By Application, 2018-2029 5. Historical Market Value (US$ Mn) By End user, 2014-2018 • Academic Institutes • Research Centers • Market Value (US$ Mn) Forecast By End user,2018-2029 6. North America Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2029 • Introduction • Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017 • U.S. • Canada 7. Latin America Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2029 • Introduction • Historical Market Size (US$ Mn) and By Country, 2014-2018 • Brazil • Mexico • Rest of Latin America 8. Europe Immune Repertoire Sequencing Market Analysis 2014–2018 and Forecast 2019–2029 • Introduction • Historical Market Size (US$ Mn) and By Country, 2014-2018 • Germany • U.K. • France • Italy • Spain • Poland • Russia • Rest of Europe • Market Size (US$ Mn) and Forecast By Country, 2018-2029 9. Asia Pacific (APAC) Immune Repertoire Sequencing Market Analysis 2014–2018 and Forecast 2019–2029 • Introduction • Historical Market Size (US$ Mn) and By Country, 2014-2018 • China • India • Japan • Australia and New Zealand • Rest of APAC • By Country • By Component • By Application • By End user 10. Middle East and Africa (MEA) Immune Repertoire Sequencing Market Analysis 2014–2018 and Forecast 2019–2029 • Introduction • Key Regulations • Historical Market Size (US$ Mn) and By Country, 2014-2018 • GCC Countries • South Africa • Rest of MEA • Market Size (US$ Mn) and Forecast By Country, 2019-2029 11. Competition Profile • Illumina, Inc. • Pacific Biosciences of California, Inc • Agilent Technologies, Inc • Oxford Nanopore Technologies, Ltd • QIAGEN N.V. • Thermo Fisher Scientific • F. Hoffmann-La Roche Ltd • BGI • Takara Bio, Inc Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Thu Sep 19 2019 Hits: 22 Rating: 0.00 Votes: 0) Rate It

• Flow Cytometry Market Global Trends, Market Share, Industry Size, Growth - Global flow cytometry market is estimated to value over USD 6.3 billion and register a CAGR of over 8% during the forecast period 2019 to 2026 . Flow cytometry is a tool used for detecting physicochemical properties of a cell or particles, based on the principle of light scattering. Cell counting, cell sorting, detection of microbes, protein engineering detection, etc. are some of the uses of flow cytometry. The advancements in technology, adoption of flow cytometry method in research and academics, initiatives in oncology and immunology research, etc. are the driving factors aiding the flow cytometry market to grow. The inclination towards adopting a more effective alternative for diagnosis of severe diseases has boosted market demand for flow cytometry techniques. Being an advanced system, the flow cytometry should be operated by well trained and skilled personnel. The equipment maintenance expenses and expenditure assigned on personnel training are quite high resulting in limited purchasing by the majority of end users. These factors are estimated to affect market growth. The cell-based flow cytometry is estimated to dominate the market. In the current era, owing to the rising focus on cell culture, target enrichment, deep cell diagnosis, isolation of cytoplasmic contents and proteins, etc. the investments and expenditure on cell-based research have increased significantly. Thus, it is an integral factor responsible for the proliferation of the segment. The research organizations are focusing on finding a better alternative for current cell analytical techniques. Flow cytometry is a major tool for in-depth study and development of cell-based assays. Research and academic institutes tend to invest more in the flow cytometry market, this is driving market growth. Initiatives for adopting advanced flow cytometry techniques and products are undertaken on a larger scale in North America. The market is boosted by the funds from the private and public sectors in this region. Furthermore, Europe has a large amount of outsourcing for clinical products by flow cytometry resulting in rising market share. The key market players are Agilent Technologies, Apogee Flow Systems, Beckman Coulter (A Subsidiary of Danaher), Cytonome St, Thermo Fisher Scientific, etc. Agilent Technologies and Thermo Fisher Scientific are expected to have a major market share owing to advanced equipment and methods. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3382&page=requestsample FutureWise Key Takeaways: ● Investment in cell-based oncology and immunology research ● Collaboration with research organizations ● Development of advanced and affordable equipment Global Flow Cytometry Market Segmentation: By Technology: ● Cell-based flow cytometry ● Bead-based flow cytometry By Product and Service: ● Reagents and consumables ● Flow cytometry instruments ● Services ● Softwares ● Accessories By Application: ● Research applications ● Clinical applications ● Industrial applications By End User: ● Academic and research institutes ● Hospitals and clinical testing laboratories ● Pharmaceutical and biotechnology companies By Region: ● North America ● Europe ● Asia Pacific ● Latin America ● Middle East and Africa Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3382&page=askfordiscount Competitive Landscape: ● Tier 1 players- established companies in the market with a major market share ● Tier 2 players ● Emerging players which are growing rapidly ● New Entrants Objectives of the Study: ● To provide with an exhaustive analysis on the flow cytometry market by technology, by product and service, by application, by end user and by region ● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ● To evaluate and forecast micro-markets and the overall market ● To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East and Africa ● To record evaluate and competitive landscape mapping-product launches, technological advancements, mergers , and expansions ● Profiling of companies to evaluate their market shares, strategies, financials , and core competencies Table of Contents 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Study Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency Used for the Study 1.5 Stakeholders 2 Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.1.2.2 Breakdown of Primaries 2.2 Market Estimation Methodology 2.2.1 Revenue Mapping-Based Market Estimation 2.2.2 Usage-Based Market Estimation 2.2.3 Primary Research Validation 2.3 Data Triangulation Methodology 2.4 Research Assumptions 2.5 Research Limitations 3 Executive Summary 4 In-Depth Insights 4.1 Flow Cytometry: Market Overview 4.2 Flow Cytometry Market, By Product & Service, 2018 vs 2026 4.3 Flow Cytometry Market, By Application, 2018 vs 2026 (USD Million) 4.4 Flow Cytometry Market, By End User, 2018 vs 2026 4.5 Geographical Snapshot of the Flow Cytometry Market 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Technological Advancements 5.2.1.2 Increasing Adoption of Flow Cytometry Techniques in Research and Academia 5.2.1.3 Growing Public-Private Initiatives in the Field of Immunology and Immuno-Oncology Researches 5.2.1.4 Rising Global Incidence and Prevalence of Hiv/Aids and Cancer 5.2.1.5 Increased Availability of Application-Specific Products 5.2.2 Restraints 5.2.2.1 Significant Product Costs 5.2.2.2 Dearth of Well-Trained and Skilled Professionals 5.2.3 Opportunities 5.2.3.1 Growing Market Presence in Emerging Countries 5.2.3.2 Evolving Pipeline for Stem Cell Research 5.2.3.3 Adoption of Recombinant Dna Technology for Antibody Production 5.2.3.4 Advent of Tandem Flow Cytometry Technologies 5.2.4 Challenges 5.2.4.1 Inadequate Research Infrastructure Across Emerging Countries 5.2.4.2 Complexities Related to Reagent Development 5.2.4.3 Limited Purchasing Power of Majority of End Users in Emerging Countries 5.3 Regulatory Challenges 5.3.1 Stringent Fda Requirements 5.3.2 Stringent Analyte-Specific Reagent (ASR) Rule 5.3.3 Lack of Well-Defined Validation Protocols for Cell-Based Assays 5.3.4 Absence of Established Laboratory-Developed Test (LDT) Guidelines on Cell-Based Fluorescence Assays 5.3.5 Greater Global Recognition for Ivd–Ce Mark Approvals 5.4 U.S. Reimbursement Scenario 6 Flow Cytometry Market, By Technology 6.1 Introduction 6.2 Cell-Based Flow Cytometry 6.2.1 Cell-Based Technologies to Dominate the Global Market Till 2026 6.3 Bead-Based Flow Cytometry 6.3.1 Procedural Advantages to Drive the Market Growth for Bead-Based Flow Cytometry Segment 7 Flow Cytometry Market, By Product & Service 7.1 Introduction 7.2 Reagents and Consumables 7.2.1 Flow Cytometry Reagents and Consumables Market Split, By Application 7.2.2 Flow Cytometry Reagents and Consumables Market Split, By Research Application 7.2.3 Flow Cytometry Reagents and Consumables Market Split, By Clinical Application 7.2.4 Flow Cytometry Reagents and Consumables Market Split, By End User 7.3 Flow Cytometry Instruments 7.3.1 Flow Cytometry Instruments Market Split, By Application 7.3.2 Flow Cytometry Instruments Market Split, By Research Application 7.3.3 Flow Cytometry Instruments Market Split, By Clinical Application 7.3.4 Flow Cytometry Instruments Market Split, By End User 7.3.5 Cell Analyzers 7.3.5.1 Flow Cytometry Based Cell Analyzers Market Split, By Application 7.3.5.2 Flow Cytometry Based Cell Analyzers Market Split, By Research Application 7.3.5.3 Flow Cytometry Based Cell Analyzers Market Split, By Clinical Application 7.3.5.4 Flow Cytometry Based Cell Analyzers Market Split, By End User 7.3.5.5 High-Range Cell Analyzers 7.3.5.5.1 High-Range Cell Analyzers Account for the Largest Share of the Cell Analyzers Market 7.3.5.6 Mid-Range Cell Analyzers 7.3.5.6.1 Wide Availability of Compact and High-Performance Analyzers in This Price Range Support Market Growth 7.3.5.7 Low-Range Cell Analyzers 7.3.5.7.1 Low-Range Analyzers Find Significant Adoption Among Price-Sensitive End Users 7.3.6 Cell Sorters 7.3.6.1 Flow Cytometry Based Cell Sorters Market Split, By Application 7.3.6.2 Flow Cytometry Based Cell Sorters Market Split, By Research Application 7.3.6.3 Flow Cytometry Based Cell Sorters Market Split, By Clinical Application 7.3.6.4 Flow Cytometry Based Cell Sorters Market Split, By End User 7.3.6.5 High-Range Cell Sorters 7.3.6.5.1 High-Range Cell Sorters Dominate the Market 7.3.6.6 Mid-Range Cell Sorters 7.3.6.6.1 Product Launches and A Balance Between Efficiency and Costs Have Enabled the Growth of This Market Segment 7.3.6.7 Low-Range Cell Sorters 7.3.6.7.1 Increasing Commercialization of Affordable Products has Driven Adoption of Low-Range Cell Sorters 7.4 Services 7.4.1 Flow Cytometry Services Market Split, By Application 7.4.2 Flow Cytometry Services Market Split, By Research Application 7.4.3 Flow Cytometry Services Market Split, By Clinical Application 7.4.4 Flow Cytometry Services Market Split, By End User 7.5 Software 7.5.1 Flow Cytometry Software Market Split, By Application 7.5.2 Flow Cytometry Software Market Split, By Research Application 7.5.3 Flow Cytometry Software Market Split, By Clinical Application 7.5.4 Flow Cytometry Software Market Split, By End User 7.6 Accessories 7.6.1 Flow Cytometry Accessories Market Split, By Application 7.6.2 Flow Cytometry Accessories Market Split, By Research Application 7.6.3 Flow Cytometry Accessories Market Split, By Clinical Application 7.6.4 Flow Cytometry Accessories Market Split, By End User 8 Flow Cytometry Market, By Application 8.1 Introduction 8.2 Research Applications 8.2.1 Pharmaceuticals & Biotechnology 8.2.1.1 Drug Discovery 8.2.1.1.1 Wide Usage of Flow Cytometry in Drug Discovery is the Primary Driver of Market Growth 8.2.1.2 Stem Cell Research 8.2.1.2.1 Accuracy and Precision of Flow Cytometry Have Made It A Prominent Tool in Stem Cell Research 8.2.1.3 in Vitro Toxicity Testing 8.2.1.3.1 Need to Reduce Time and Cost of Drug Development Processes Will Be A Key Factor Driving Market Growth 8.2.2 Immunology 8.2.2.1 Flow Cytometry Plays A Vital Role in Immunology Studies 8.2.3 Cell Sorting 8.2.3.1 The Increase in Cell-Based Research Activity has Boosted Growth in This Application Segment 8.2.4 Apoptosis 8.2.4.1 Flow Cytometry Techniques are Used to Identify Changes Occurring During Apoptosis 8.2.5 Cell Cycle Analysis 8.2.5.1 Any Abnormality in Dna Content Can Be Detected Using Flow Cytometry 8.2.6 Cell Viability 8.2.6.1 Cell Viability is A Key Parameter Studied Using Flow Cytometry 8.2.7 Cell Counting 8.2.7.1 Flow Cytometry Allows for Easy Differentiation of Cells Via Scattering Or Staining 8.2.8 Other Research Applications 8.3 Clinical Applications 8.3.1 Cancer 8.3.1.1 Cancer Applications Include Determination of Tumor Malignancy and Chromosome Enumeration 8.3.2 Hematology 8.3.2.1 Flow Cytometry Can Help Identify A Wide Variety of Cell Surfaces and Cytoplasmic Antigens 8.3.3 Immunodeficiency Diseases 8.3.3.1 Flow Cytometry Allows for Simultaneous, Multi-Parameter Cell Analysis 8.3.4 Organ Transplantation 8.3.4.1 Use of Flow Cytometry to Reduce Organ Rejection Rates has Contributed to Market Growth 8.3.5 Other Clinical Applications 8.4 Industrial Applications 8.4.1 Wide End User Base to Drive Industrial Application Market Growth 9 Flow Cytometry Market, By End User 9.1 Introduction 9.2 Academic and Research Institutes 9.2.1 Strengthening Research Pipeline and Industry-Academia Collaboration to Drive the Market Growth 9.3 Hospitals & Clinical Testing Laboratories 9.3.1 Rising Awareness and Disease Prevalence Have Sustained the Demand for Flow Cytometry 9.4 Pharmaceutical & Biotechnology Companies 9.4.1 Growing Drug Discovery Activity to Drive Market Growth 10 Flow Cytometry Market, By Region 10.1 Introduction 10.2 North America 10.2.1 US 10.2.1.1 High Adoption of Advanced Flow Cytometry Products Among End Users to Drive Market Growth in the Us 10.2.2 Canada 10.2.2.1 Availability of Public and Private Funding for Research Activities to Boost the Demand for Flow Cytometry Products in Canada 10.3 Europe 10.3.1 Germany 10.3.1.1 Greater Outsourcing of Clinical Diagnostic Services to Be the Key Trend in the German Flow Cytometry Market 10.3.2 UK 10.3.2.1 UK to Witness Growing Acceptance of Flow Cytometry Products for Clinical Diagnostics 10.3.3 France 10.3.3.1 Training and Awareness Programs By Social Organizations and Key Players Expected to Fuel the Adoption of Flow Cytometry 10.3.4 Rest of Europe 10.4 Asia Pacific 10.4.1 Japan 10.4.1.1 Strong Infrastructure and Favorable Market Outlook Have Sustained Japan’s Dominance in the APAC Market 10.4.2 China 10.4.2.1 China Accounts for the Second-Largest Share in the APAC Market 10.4.3 India 10.4.3.1 High Incidence of Hiv/Aids and Cancer to Drive the Demand for Flow Cytometry Instruments in India 10.4.4 Rest of Asia Pacific 10.5 Latin America 10.5.1 Brazil 10.5.1.1 Brazil Dominates the Latam Market for Flow Cytometry 10.5.2 Mexico 10.5.2.1 Free Trade Agreements Will Support Imports, Accessibility to Flow Cytometry Instruments in Mexico 10.5.3 Rest of Latin America 10.6 Middle East and Africa 10.6.1 Low Disposable Income and Need for Infrastructural Development Hinder Market Growth 11 Competitive Landscape 11.1 Overview 11.2 Global Market Share Analysis (2018) 11.3 Competitive Scenario 11.3.1 Key Product Launches and Approvals (2014–2018) 11.3.2 Key Agreements, Partnerships, and Collaborations (2014–2018) 11.3.3 Key Acquisitions (2014–2018) 11.3.4 Key Expansions (2014–2018) 11.4 Competitive Leadership Mapping 11.4.1 Competitive Leadership Mapping: Major Market Players (2018) 11.4.1.1 Vanguards 11.4.1.2 Innovators 11.4.1.3 Dynamic Players 11.4.1.4 Emerging Companies 11.4.2 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-UPS (2018) 11.4.2.1 Progressive Companies 11.4.2.2 Starting Blocks 11.4.2.3 Responsive Companies 11.4.2.4 Dynamic Companies 12 Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise Perspective) 12.1 Agilent Technologies 12.2 Apogee Flow Systems 12.3 Beckman Coulter (A Subsidiary of Danaher) 12.4 Becton, Dickinson and Company 12.5 Biomérieux S.A. 12.6 Bio-Rad Laboratories 12.7 Cytonome St 12.8 Enzo Life Sciences (A Wholly Owned Subsidiary of Enzo Biochem, Inc.) 12.9 Luminex 12.10 Merck KGaA 12.11 Miltenyi Biotec 12.12 Sony Biotechnology (A Wholly Owned Subsidiary of Sony Corporation of America) 12.13 Stratedigm 12.14 Sysmex Partec (A Subsidiary of Sysmex Corporation) 12.15 Thermo Fisher Scientific 13. Assumptions and Acronyms 14. Research Methodology 15. List of Sources of Information (Primary and Secondary) Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Thu Sep 19 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• 4th Global Conference and Expo on Vaccines Research & Development - th Global Conference and Expo on Vaccines Research & Development (Vaccines R&D-2020), which will be held during February 10-11, 2020 in Lisbon, Portugal is now an established event, attracting global participant’s intent on sharing, exchanging and exploring new avenues of Vaccines Research & Development and related research and latest developments. The event will have 5-6 world level (Highly cited class) Plenary speakers, established Keynote speakers, active Invited speakers and fresh contributed speakers. In addition, variety of poster presentations along with workshops and special sessions would be interested in audience. We are looking forward to seeing you at Vaccines R&D-2020 in Lisbon, Portugal. Young Researchers Opportunity: We make sure to support and motivate 'Young Researchers' by: Establishing their academic and professional relationships. Improving their morale and confidence of presenting research in an international platform. Interacting with expertise in their respective departments. Clearing your inhibitions of adjusting to the foreign environment. Providing a holistic experience of academic tourism. (Added: Thu Sep 19 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Cell Viability Assays Market Global Trends, Market Share, Industry Size, Growth - Global Cell Viability Assays Market is estimated to value over USD 3.9 billion by 2026 end and register CAGR of over 7.1% by 2026 end. The growing burden of infectious and chronic diseases, increasing focus on cell-based therapeutic development and rising demand for cell-based arrays for research activities are important factors that drive the global cell viability assays market further. According to the statistics provided by the World Health Organization (WHO), chronic diseases are responsible for around 60% of all deaths across the world and it is predicted by WHO that the occurrence of chronic diseases shall increase by around 57% by 2020. This rising incidences of chronic diseases have increased the demand for efficient healthcare infrastructure. Moreover, according to WHO, nearly 4 out of 5 deaths around the world in 2014, especially in developing countries, occurred due to chronic diseases. According to the Centre for Disease Control and Prevention (CDC), the prevalence of chronic diseases was the main reason for disabilities and deaths in the US in the year 2017. Around 130 million Americans had at least one chronic disease. Additionally, the increase in demand for healthcare spending is due to the rise of lifestyle-related and age-related chronic disease. Cancer and cardiovascular diseases are the new causes of deaths, especially in the developing economies, as a result of rapid urbanization, changing dietary habits, sedentary lifestyles, widespread availability of tobacco products and rising obesity levels. According to the estimates presented by the CDC, these diseases are the major reason for the death of over 2 million citizens per year in the United States. This growing load of chronic diseases is predicted to propel the global cell viability assays market growth. Stem Cell Research is Projected to Showcase Remarkable Market Growth Over the Forecast Period The stem cell research segment is estimated to register a high CAGR value over the forecast period owing to the increase in the research and development activities and funds raised by various organizations for these activities. As per the data from the National Institute of Health (NIH), around USD 2000 million were granted for stem cell research and development activities in the fiscal year 2018. An increase in the number of cell-based treatment centres has assisted in driving stem cell research. Around 580 such centres were established in the US in the year 2015. All these factors are responsible for the proliferation of the global cell viability assays market. North America is predicted to dominate the market over the forecast period owing to the increase in the prevalence of the chronic disease, high-quality infrastructure and investment initiatives taken by the government. Additional advantages like rising research and development expenditure for the healthcare sector, availability of insurance coverage for lab testing procedures propel the market growth further. Key market players include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton, Dickinson and Company, Promega Corporation, Biotium, Abcam PLC, Creative Bioarray, Biotek Instruments, Perkinelmer. Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3384&page=requestsample Global Cell Viability Assays Market Segmentation: By Product · Consumables o Reagents o Assay Kits § Tetrazolium Reduction Assay Kits · Mtt Assay Kits · Other Tetrazolium Assay Kits § Resazurin Cell Viability Assay Kits § Calcein-Am Cell Viability Assay Kits § Other Assay Kits o Microplates · Instruments o Automated Cell Counters o Flow Cytometers o Spectrophometers o Cell Imaging & Analysis Systems By Cell Type · Human Cells · Animal Cells · Microbial Cells By Application · Drug Discovery and Development · Basic Research · Stem Cell Research · Clinical and Diagnostic Applications · Other Applications By Region · North America · Europe · Asia Pacific · Latin America · Middle East & Africa Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3384&page=askfordiscount Competitive Landscape: · Tier 1 players- established companies in the market with a major market share · Tier 2 players · Emerging players which are growing rapidly · New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: · To provide with an exhaustive analysis on the global cell viability assays market by product, by cell type, by application and by region · To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) · To evaluate and forecast micro-markets and the overall market · To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa · To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions · Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2 Research Methodology 2.1 Research Data 2.1.1 Secondary Sources 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Sources 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Market Share Estimation 2.5 Assumptions for the Study 3 Executive Summary 4 Premium Insights 4.1 Cell Viability Assays Market Overview 4.2 Cell Viability Assays Market: Geographic Overview (2017) 4.3 Regional Mix: Cell Viability Assays Market (2018–2026) 4.4 Asia Pacific: Cell Viability Assays Market, By End User & Country (2017) 4.5 Cell Viability Assays Market: Developed vs Developing Markets 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Rising Incidence and Prevalence of Chronic and Infectious Diseases 5.2.1.2 Growing Availability of Funds for Research 5.2.1.3 Rising Demand for Cell-Based Assays in Research 5.2.1.4 Increasing Focus on the Development of Cell-Based Therapeutics 5.2.2 Restraint 5.2.2.1 High Cost of Instruments 5.2.3 Opportunities 5.2.3.1 Emerging Markets 5.2.3.2 Growing Focus on Stem Cell Research 6 Cell Viability Assays Market, By Product 6.1 Introduction 6.2 Consumables 6.2.1 Reagents 6.2.2 Assay Kits 6.2.2.1 Tetrazolium Reduction Assay Kits 6.2.2.1.1 Mtt Assay Kits 6.2.2.1.2 Other Tetrazolium Assay Kits 6.2.2.2 Resazurin Cell Viability Assay Kits 6.2.2.3 Calcein-Am Cell Viability Assay Kits 6.2.2.4 Other Assay Kits 6.2.3 Microplates 6.3 Instruments 6.3.1 Automated Cell Counters 6.3.2 Flow Cytometers 6.3.3 Spectrophotometers 6.3.4 Cell Imaging & Analysis Systems 7 Cell Viability Assays Market, By Cell Type 7.1 Introduction 7.2 Human Cells 7.3 Animal Cells 7.4 Microbial Cells 8 Cell Viability Assays Market, By Application 8.1 Introduction 8.2 Drug Discovery and Development 8.3 Basic Research 8.4 Stem Cell Research 8.5 Clinical and Diagnostic Applications 8.6 Other Applications 9 Cell Viability Assays Market, By End User 9.1 Introduction 9.2 Pharmaceutical & Biotechnology Companies 9.3 Academic & Research Institutes 9.4 Hospital & Diagnostic Laboratories 9.5 Other End Users 10 Cell Viability Assays Market, By Region 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.3 Europe 10.3.1 Germany 10.3.2 France 10.3.3 UK 10.3.4 Italy 10.3.5 Spain 10.3.6 Rest of Europe 10.4 Asia Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Rest of Asia Pacific 10.5 Latin America 10.6 Middle East & Africa 11 Competitive Landscape 11.1 Overview 11.2 Market Share Analysis 11.2.1 Market Share Analysis: Cell Viability Assay Kits Market 11.3 Competitive Situation and Trends 11.3.1 Product Launches 11.3.2 Expansions 11.3.3 Acquisitions 11.3.4 Other Strategies 12 Company Profiles (Business Overview, Products Offered, Recent Developments, SWOT Analysis, FutureWise Perspective)* 12.1 Thermo Fisher Scientific 12.2 Merck KGaA 12.3 Bio-Rad Laboratories 12.4 GE Healthcare 12.5 Danaher Corporation 12.6 Becton, Dickinson and Company 12.7 Promega Corporation 12.8 Biotium 12.9 Abcam PLC 12.10 Creative Bioarray 12.11 Biotek Instruments 12.12 Perkinelmer 13. Research Finding and Conclusion 14. Appendix 15.1 Research Methodology 15 .2 Research Data Source Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com (Added: Thu Sep 19 2019 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• Medical Ceramics Market, Global Forecast, Ceramics used in Application, Regions and Companies - Medical ceramic refers to a kind of ceramic that is used in medical application like; to create prosthetic denture, heart valve, Suture and Pacemaker Electrode etc. ceramic is an inorganic compound made up of metal and non-metal and its material are brittle, hard and strong after heated at very high temperature. Medical ceramic is fabricated as non-toxic and biocompatible which is also called bioceramics. Medical ceramic in dental application has been rising and it will dominate the market in anticipated year. Global Medical Ceramics Market is expected to surpass US$ 26 Billion mark by the year end of 2025. There are various significant factors that influence the medical ceramic market to outperform; rising private investment in research & development of medical ceramics, adoption of medical ceramics in various healthcare products like manufacturing of medical devices and widely used in surgical implant etc, gradual decreasing cost of medical ceramics material, increasing number of non invasive procedure like implant of dental, orthopedic and cardiovascular etc. The other prime factors also include rising geriatric population lead to rise of incidence in dental, orthopedic and cardiovascular disease that would further demand various products made up of medical ceramics like heart valve, hip replacement, knee replacement etc. Access full Research: https://www.renub.com/medical-ceramics-market-p.php Renub Research report titled “Medical Ceramics Market, Global Forecast, by Material Type [Bio-inert (Alumina and Zirconia), Bioactive (Hydroxyapatite and Glass Ceramics), Bioresorable, Piezo-ceramics], Ceramics used in Application (Regenarative Procedures, Medical Equipments, Dental, Orthopedic), Regions (North America, Europe, Asia-Pacific & Rest of World), Companies (CeramTec GmbH, Kyocera Corporation, Morgan Advanced Materials, H.C. Stark, 3M, DSM, NGK Spark Plug, DePuy Synthes, Zimmer Biomet Holding Inc., Straumann)” provides a complete analysis of Global Medical Ceramics Market. Medical Ceramics Market Insight by Material The report studies the classification of medical ceramics: [Bio-inert (Alumina and Zirconia), Bioactive (Hydroxyapatite and Glass Ceramics), Bioresorable and Piezo-ceramics market. currently, there are huge demand of medical ceramics in dental and orthopedic application. In this report, we have explained the market by each ceramics material used in medical application along with current and future demand of medical ceramics materials. Application – Prosthetic Dental is one of the Most Significant Application in Global Medical Ceramics Market Here the report studies the medical ceramics market by application into four parts; Regenarative Procedures, Medical Equipments, Dental Applications and Orthopedic Applications. Our research analysis would provide the holistic perspective on each application like the factor that will drive the dental and orthopedic application in global ceramics market. In addition it also studies the challenging factors that would hinder the application market of medical ceramics. Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=medical-ceramics-market-p.php Region – North America alone will dominate Medical Ceramics Market In geographical perspective, North America will hold the largest share of medical ceramics market in forecast period of time. Here the report comprehensively explains the regional profile of medical ceramics market; North America, Europe, Asia-Pacific and ROW. All the 10 Companies Studied in the Report have been Studied from 3 Points • Company Overview • Business Strategy /Mergers & Acquisition • Financial Insight Companies Covered in the Report: 1. CeramTec GmbH 2. Kyocera Corporation 3. Morgan Advanced Materials 4. H.C. Stark 5. 3M 6. DSM 7. NGK Spark Plug 8. DePuy Synthes 9. Zimmer Biomet Holding Inc. 10. Straumann Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=medical-ceramics-market-p.php Medical Ceramics By Type of Material Covered in the Report: • Bio-inert • Bioactive • Bioresorable • Piezo-ceramics By Application Medical Ceramics Covered in the Report: • Ceramics used in Regenarative Procedures • Ceramics used in Medical Equipments • Ceramics used in Dental Applications • Ceramics used in Orthopedic Applications Regional Market Covered in the Report: • North America • Europe • Asia-Pacific • Rest of World If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team. Contact Us Email: info@renub.com Phone: +1-678-302-0700 Web: www.renub.com (Added: Thu Sep 19 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Telemedicine Market Size, Share and Forecast 2019-2026 - Market Overview: Increase in rural health issues and hospitalizations, lack of resources to meet the increased cases, etc., necessitated the growth of global Telemedicine market. Telemedicine is two-way, real-time interactive communication between a patient and healthcare provider at a different place. This is supported audio and video equipment along with integrated medical devices and hence enables the clinicians to evaluate, diagnose and treat patients remotely. Studies reveal that over 62 million people lack access to adequate healthcare services. Market Dynamics: Treatment by through this method is particularly helpful in rural areas, where there is a lack of accessibility to both primary health care and specialty care due to the shortage of healthcare providers.Faster access to healthcare, which is a crucial factor in improved patient engagement and better outcomes. Progress in healthcare industry towards the value-based care and use of telehealth technologies results in positive outcomes including fewer hospital re-admissions, more faithful following of prescribed courses of treatment, and faster recovery than that of patients not receiving the foreign intervention. Telemedicine allows hospitals to create a network to support each other. By easily sharing their expertise outside their institutions, doctors can offer incredible value to their medical colleagues and those colleagues’ patients. All these advantages and ease of access are driving the global telemedicine market. Market Segmentation: Based on specialty area into General Consultation, Cardiology, Dermatology, Neurology, Gynecology, Trauma Care, Ophthalmology, Orthopedics, Psychiatry, Pathology, General Surgery, and Others. Based on End-Users into Hospitals, Clinics, Patients and others. Based on technology into Hardware, Software, and Telecommunications. Based on type of telemedicine into Telehospitals/Clinics, Telehome, and health. Geographical Analysis: By Geography, the market is segmented into, North America, Europe, South America, Asia Pacific, The Middle East and Africa Competitive Analysis: Some of the key players include American Well, ConsultADoctor, Teladoc, MeMD, iCliniq, CareClix, others. View full report: https://www.datamintelligence.com/research-report/telemedicine-market Download free sample: https://www.datamintelligence.com/download-sample/telemedicine-market About Us: DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com (Added: Thu Sep 19 2019 Hits: 23 Rating: 0.00 Votes: 0) Rate It

• October 30 - 11th International Conference on Dental science and education will be an inventive and helpful universal social event reflecting the heading of worldwide meetings on Dental and Oral health and offers a broad assortment of redirection to individuals from all foundations. The conference is on April 20-21, 2020 at Singapore city, Singapore, based on the topic “Imaginative Thoughts and Propelled Systems in Dental Science and Oral Hygiene”. (Added: Thu Sep 19 2019 Hits: 8 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... [>>]